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Abstract 
 
 
Aging results in a loss of skeletal muscle strength. This decline is further augmented by 
low levels of ovarian hormones in females, such as experienced following menopause. 
Power is arguably more critical to muscle function than is maximal strength, yet the 
impact of and mechanisms whereby aging and hormones impact muscle power are 
largely unknown. The studies of this dissertation utilize mouse models to investigate the 
impact of aging and removal of ovarian hormones on skeletal muscle maximal power and 
submaximal strength. The results of these studies are the first to convincingly 
demonstrate that ovarian hormones provide similar input to skeletal muscle function 
during adulthood and aging in females. This work lends further evidence for a critical 
transition in skeletal muscle function between 24 and 28 months of age in mice.   
Additionally, these dissertation studies reveal impacts of both aging and ovarian 
hormones on redox balance (oxidative stress levels and antioxidant system response) in 
skeletal muscle. Oxidative damage to contractile proteins of skeletal muscle increases 
with aging, and removal of ovarian hormones has a similar effect. It is speculated the 
increase in damage is a result of the decline in protein expression of key antioxidants, 
such as superoxide dismutase and glutathione peroxidase, that occurs with aging and 
when ovarian hormones are absent. Taken together, the results of this dissertation are 
suggestive of an important role of ovarian hormones in maintaining redox balance in 
skeletal muscle, particularly during aging in females. Further studies investigating 
methods to mitigate age-related changes are warranted.
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Introduction: 
 
The loss of skeletal muscle strength experienced with aging is detrimental to one’s ability 
to function and carry out tasks of daily living. Injury resulting from falls is one of the 
leading causes of hospitalizations in the elderly, with a noticeably greater incidence of 
falls and hospitalizations in women than in men [1]. Increased falls and resulting injury is 
associated with declines in muscle strength [1] , which leads to diminished independence 
and increased incidence of co-morbidities. Women and men experience different rates of 
skeletal muscle loss with aging [2]. This sex difference is the greatest at the time of 
menopause, and has been associated with the concurrent loss of estrogen [3]. Despite this 
knowledge that there are sex differences in the way that men and women age, the 
majority of studies in humans and rodents aimed at uncovering the mechanisms of age-
related strength loss have included only males. This male-biased research focus on aging 
in skeletal muscle is a major limitation of current studies and results in a gap in 
understanding of the mechanisms through which estrogen deficiency detrimentally 
affects skeletal muscle in females and contributes to loss of strength.  
 
While isometric force generation is a component of muscle function, dynamic 
contractions (including force generation at velocity and power) are arguably better 
predictors of the muscles ability to perform. Previous work by our laboratory has 
demonstrated that the impact of aging on muscle strength was muscle-fiber-type 
dependent. Aging impacted muscle components related to speed of contraction, even 
when muscle force generation was not impacted [4]. Studies in elderly humans have 
estimated that velocity and muscle power are stronger predictors of muscle function 
compared with maximal force or muscle cross sectional area [5-13] . These findings 
highlight the importance of velocity when investigating the impact of aging on muscle 
strength in vivo.  
 
Previous work in rodents demonstrates that ex vivo muscle force generation in adult mice 
is lower when estradiol is lacking [14], which correlates with a decline in strong binding 
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myosin during contractions [15] and a decrease in phosphorylation of the regulatory light 
chain of myosin [16]. These beneficial effects of estradiol on myosin and muscle force 
generation appear to be altered with aging [17]. Thus mechanisms of estradiol’s actions, 
especially as they relate to aging, require further investigation. A possible contributing 
mechanism to changes observed with estradiol deficiency is through alteration of the 
redox balance of skeletal muscle. Previous studies have shown that estradiol can affect 
oxidative damage caused by free radicals [18-24] and furthermore that these oxidative 
modifications accumulate with aging [25-36]. No studies have fully elucidated the 
pathway(s) through which estrogenic effects on redox balance and maintenance of force 
generation may occur, although there is a growing body of evidence for an ERα mediated 
mechanism [37-39].  
 
Therefore, the primary goals of this dissertation are to 1) determine the extent to which 
and mechanism(s) whereby estradiol deficiency alters muscle strength and power in adult 
and aging female mice; 2) elucidate the impact of estradiol deficiency and aging on 
oxidative stress and damage to skeletal muscle and; 3) measure changes in antioxidant 
availability that may impair the redox-imbalance in aged and estradiol deficient skeletal 
muscle. Multiple studies have been conducted in order to test the over-arching hypothesis 
that estradiol deficiency is detrimental to many aspects of skeletal muscle contractile 
function.  
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Chapter #1: Literature Review  
 
1.1 Age-related loss of muscle mass 
 
Skeletal muscle mass is lost at a rate of approximately 1% per year past the age of 50 
years [2]. The decrease in mass is attributed to a loss of both type 1 and type 2 fibers [40-
43]. This loss of fibers translates to a loss of force production and muscle power, the 
latter of which is thought to be the major contributing factor to impair performance of 
daily living tasks (e.g., rising from a chair or walking stairs) [44, 45].  This decline in 
skeletal muscle mass and force production is termed sarcopenia and is associated with an 
increase in co-morbidity in aging [46]. The loss of muscle mass is due in part to loss of 
motor unit innervation, resulting in larger motor units as some denervated fibers are 
“adopted” by functioning motor units [1]. 
 
Although other motor units adopt many of the denervated fibers, yielding large motor 
units, a portion of these denervated fibers are not adopted. Without innervation these 
fibers will die, contributing to the sarcopenia witnessed with aging.  There is some 
disagreement as to whether fast-twitch (type 2) fibers are lost preferentially over slow-
twitch (type 1) fibers [47]. Previously it was accepted that fast-twitch were lost with 
aging whereas slow-twitch fibers were preserved. However, it has been proposed that this 
in fact is not the case; both fiber types are lost at a similar rate with aging [42, 47] and the 
number of fibers co-expressing as both fast and slow twitch (i.e., mixed fibers) increases 
with age [41, 48]. The increase in mixed fibers has consequences for not only force 
production of muscles but also the types of tasks that the muscles are able to perform. 
Thus in addition to the increasing size of the motor unit that occurs with denervation and 
re-innervation, there is a decrease in fast-twitch motor units as these become mixed fiber 
motor units [49, 50]. 
 
Another contributing factor to sarcopenia is muscle atrophy. Although muscle atrophy 
results from the loss of fibers, as previously discussed, decreased size of the remaining 
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muscle fibers is also observed with aging [51, 52]. Cross sectional area appears to be less 
affected by aging in type 1 fibers than in type 2 fibers where up to a 50% decrease is 
observed [46]. This loss of fiber number and size leads to a decline in whole tissue mass 
and force production [53, 54]. Muscle mass has been shown to decline by as much as 
40% in humans from age 20-80 years [51] with a similar decline in the cross sectional 
area and the force producing capacity of the muscle [55]. Similarly, male and female 
rodents lose muscle mass and fiber size with age [40, 52, 56]. 
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1.2 Age-related loss of force generation, velocity of contraction, and power 
 
Loss of force generation outpaces loss of muscle mass with aging [57] indicating other 
contributing factors to muscle force production. In addition to loss of muscle mass, loss 
of force can be attributed to changes in the quality of muscle [58, 59], specifically by 
altering the contractile proteins (e.g., myosin). Myosin is the main contractile protein that 
makes up the thick filament in skeletal muscle’s contractile apparatus. The interaction of 
myosin heads with the thin filament, in a strong binding state, causes force to be 
generated at the molecular level during a contraction. With aging there is a decrease in 
the strong binding of myosin during muscle contraction, resulting in reduced force 
production of individual fibers [60-62]. There is further evidence that the rate of myosin 
interaction with the thin filament is also decreased with aging [63]. The decline in strong 
bound myosin and rate of myosin binding [64], compounded with a decrease in the 
quantity of myosin protein [65-67], plays a role in the loss of skeletal muscle force 
generation that occurs in aging.  
 
In addition to changes in myosin, it has also been proposed that alterations in the 
neuromuscular junction (NMJ) diminish force signal transmission [68]. Specifically, it 
has been suggested that disorganization of the synaptic cleft leads to disassembly of the 
NMJ which likely contributes to the aforementioned alterations [69, 70]. Proper 
functioning of agrin, a signaling factor for the formation of the NMJ, is necessary to 
maintain acetylcholine release and structural organization [69]. Cleavage of agrin results 
in a sarcopenia phenotype [70] similar to that observed with aging, lending further 
support to the importance of a properly organized NMJ in maintenance of skeletal muscle 
mass and function. 
 
Combined, these age-related changes result in loss of force production that is observed in 
both men and women, with the most noticeable loss occurring at age 50 years and greater 
at which point a rapid decline in force production occurs in women, coinciding with 
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menopause [2].  Due to the high inter-individual variability associated with aging, the 
cross-sectional study design employed by the majority of studies may tend to 
underestimate the decline in muscle size and force production. Unfortunately, 
longitudinal studies that better identify the age-related alterations that occur in skeletal 
muscle [51], present far greater challenges in implementation and are less frequently 
employed. Another important note about current studies investigating the age-related 
changes in skeletal muscle, is that the majority of these studies have focused solely on 
males [46, 51]. Differing physiological changes that occur during aging between males 
and females suggest that the mechanisms behind aging-associated skeletal muscle force 
loss are also different between sexes [71, 72]. One of the primary focuses of this 
dissertation is to contribute additional studies focused on females to better delineate 
female-specific changes with aging. 
 
Another functional change that occurs with aging is a decrement in contractile velocity of 
muscle movement. Power, the ability to produce force at a specific velocity, is arguably 
more critical to study than isometric strength as people experience a 3.5% per year rate of 
decline in power compared to the declines of 1.5% per year in muscle strength [73]. 
Additionally, power is a more comprehensive measurement of muscle function and 
changes to the muscular system than isometric strength and is a better predictor of muscle 
overall function [74-77]. However, the majority of studies that investigate changes in 
muscle with aging focus on maximal contraction strength; relatively few studies explore 
age-related changes in velocity and power.  
 
As with much muscle aging research, investigations into alterations in muscle power in 
humans have focused on men. From the few studies that have considered sex differences, 
it is clear that muscle power decline with aging in women is different than what is 
observed in men. The results of studies carried out to date suggest an age-related decline 
in muscle power, specific to changes in the peripheral nervous system and intrinsic 
factors of the muscle. A decline in power can also be due to atrophy (i.e., less motor 
units); however, the majority of studies attribute power loss to a decline in torque 
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production and velocity with minimal impact of muscle size [77, 78]. Furthermore, it was 
suggested that the decline in velocity is due to slower development of twitch contraction 
[78]. It is evident that muscle power is impacted by a multitude of factors [79, 80], of 
which the contributions at a cellular level are not yet defined [73]. If we are to improve 
muscle power maintenance with aging, it is imperative that cellular mechanisms be 
understood.  
 
Investigations utilizing rodent models, such as those performed in this dissertation, are 
necessary in order to isolate factors that contribute to strength and power, as 
manipulations of hormones, proteins, etcetera are easily performed. Only by isolating 
pathways can we identify the mechanisms contributing to changes in muscle strength and 
power with aging. Several studies to date have sought to identify changes in power with 
aging in mice. Collectively these studies confirm an age-related decline in muscle power 
that is exacerbated when the muscle is required to contract at near maximal force output 
[56, 81-83]. These studies fail to fully address the contribution of velocity to power 
production and results are limiting as these studies used only male rodents and the 
muscles were tested ex vivo [83]. A previous study performed in our lab found evidence 
for a slower rate of contraction and relaxation in muscles from female mice in muscles ex 
vivo [4], suggestive of alterations in velocity with aging. Thus, a main focus of this 
dissertation is to investigate the effect of age on muscle power production across a wide 
range of velocities in female mice. 
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1.3 Estrogens and estrogen receptors 
 
Estrogen, the main female sex hormone, is a polyphenol biomolecule produced mainly by 
the ovaries, although there is also limited production by other tissues (i.e., adipose tissue). 
Estrogen naturally occurs in three forms: estrone (E1), estradiol (E2), and estriol (E3), 
numbered thus based on the number of hydroxyl groups present. Estradiol (E2) is the 
most bioavailable form of estrogen in the body and is found as 17α-estradiol and 17β-
estradiol [84]. Plasma concentrations of 17β-estradiol in premenopausal women are ~0.2–
1.0 nmol/L; however, these levels can be considerably higher in various tissues [84]. 
 
Many of estrogen’s functions are mediated through the estrogen receptor (ER). Three 
types of estrogen receptors have been identified, ER alpha, ER beta, and G-protein 
coupled ER (GPER) [85-87]. Estrogen receptors alpha and beta primarily localize to the 
nucleus to have their effects, although a small percentage can be found in the cytoplasm 
[88]. The main ligand for ERs, 17β -estradiol, is hydrophobic which allows it to diffuse 
through membranes into the cells where it can bind the receptor [89]. ERs have been 
shown to play a role in gene expression (genomic effect) and cell signaling (non-genomic 
effect) [90].  
 
The genomic effects have been largely attributed to be due to ERs alpha and beta, 
whereas the immediate non-genomic effects are hypothesized to occur mainly through 
the membrane-bound GPER [84, 91-94]. There is evidence for tissue-localization of 
specific receptor types [90]. Estrogens have been shown to have widespread effects in 
many body systems (i.e., nervous system, cardiovascular system, reproductive system, 
immune system, and musculoskeletal system); however, how estrogens function in these 
systems and to what extent the observed effects are through genomic and non-genomic 
actions is highly tissue specific and new details are continually being elucidated. Because 
estradiol is the most bio-available form of estrogen, it is the hormone of interest for these 
dissertation studies. 
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1.4 Age-induced decline in estradiol production 
 
In women estradiol levels fluctuate based on menstrual cycle phase from the time of 
puberty up until the time of menopause. The National Institute on Aging and others 
define menopause as 12 consecutive months without menstruation. At the time of the 
menopausal transition, which averages age 51 in women, there are alterations in the 
levels of several hormones, the most notable of which is the drastic decline in estradiol 
[95]. Decline in ovarian follicle number below a critical threshold is considered to be the 
main driving force in menopause, ultimately resulting in ovarian failure [96]. Since the 
ovaries are the primary estradiol producing tissue in the body, ovarian failure causes a 
sharp decline in estradiol levels. The low levels of estradiol adversely affect various body 
functions including bone turnover, lipid levels, and skeletal muscle function [97, 98].  
 
A similar cycle of fluctuating estradiol levels is observed in mice. This is termed the 
estrous cycle [99, 100] and it begins at the time of sexual maturity (approximately 2-3 
months of age) continuing until ovarian failure/ senescence, at 18-20 months of age [17, 
100]. The estrous cycle is similar to the menstrual cycle in that hormone (estrogens, 
follicle stimulating hormone, progesterone, and inhibin) levels fluctuate in a regular, 
cyclic manner within a physiological range and changes in these levels of hormones 
determines fertility. Similar to menopause in women, declining levels of estradiol in 
aging female mice result in ovarian senescence [100].  
 
The ovariectomy mouse model is commonly used as an induced menopause model in 
adult female mice [101-103]. Although this approach results in an abrupt decline in 
estradiol levels as opposed to the more gradual decline observed in menopause, it is a 
useful tool to study the effects of estradiol depletion without confounding effects 
associated with aging. An approach used within our lab to investigate the effects of 
estradiol treatment is to ovariectomize mice and replace the hormones lost by removal of 
the ovaries with 17-β estradiol [14, 15, 17], mimicking estrogen-based hormone 
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replacement therapy in women. This approach permits for the determination that estradiol 
is the ovarian hormone implicated, versus other ovarian hormones such as progesterone. 
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1.5 Effects of estrogens on skeletal muscle strength and power 
 
Hormone therapy (estrogen-based and combined estrogen/progesterone treatments) has 
been shown to maintain muscle strength in post-menopausal women [104]. A growing 
body of evidence confirms the detrimental effects of estrogen loss on skeletal muscle. It 
has been shown that the loss of estradiol at menopause has a significant impact on muscle 
power in women. One study found that premenopausal women have 95% greater power 
than post-menopausal women [105] , and in post-menopausal women hormone therapy 
can partially protect against that loss. Some attempts at elucidating the mechanism of this 
decline when estradiol is low have been undertaken, results of which suggest a role in 
mitochondrial function [106]. However, as previously discussed, it can be challenging to 
investigate mechanisms in humans, and studies in rodents are necessary to probe cellular 
mechanisms. 
 
Previous studies in rodents have shown that loss of estradiol results in decreased force 
generating capacity as well as reduced myosin function [98, 107, 108]. Furthermore, 
restoration of estradiol levels seems to recover muscle function [15]. This is further 
substantiated by a meta-analysis which supported estrogen-based hormone replacement 
therapy in post-menopausal women as well as estradiol treatment of female 
ovariectomized rodents to improve muscle force production [104]. The extent to which 
estrogen maintains muscle function remains controversial and the mechanisms by which 
this is accomplished are not fully understood [109] although it is plausible that this 
hormone affects redox balance (oxidant/antioxidant ratio) in skeletal muscle since it 
affects redox balance in other tissues (discussed in further detail in section 3). To date, no 
studies have been able to convincingly demonstrate a redox mechanism for the effects of 
estradiol on skeletal muscle.  
 
To further delineate effects of estrogens and other sex hormones on muscle force 
production, a number of studies have investigated the correlation between menstrual 
cycle phase (high or low levels of estrogen and progesterone) and performance in 
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women. Studies investigating whole body submaximal and maximal performance (e.g., 
running, cycling, etc) found little to no effect of menstrual cycle phase on muscle 
performance [110-113]. Whereas studies investigating strength of a single muscle over 
the course of the menstrual cycle give evidence for estradiol-driven changes in maximal 
output [114]. Further, the role of female sex hormones on skeletal muscle performance is 
still unclear.  
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1.6 Effects of aging on oxidative stress and damage 
 
The production of free radicals (ROS) at low levels is necessary for signaling, for 
example during gene regulation and the immune response [115, 116]. As such, limited, 
small amounts of ROS production are good and necessary for the body, but large 
amounts can be detrimental.  The oxidative stress/redox theory of aging is a leading 
theory explaining many of the physiological changes that accompany aging in the body 
[117-119]. This theory of aging, introduced by Denham Harman in 1956 [120], postulates 
that the hallmarks of aging are due to an increased formation of free radicals resulting in 
oxidative stress and damage to tissues. It has been subsequently supported by numerous 
studies showing the accumulation of oxidative damage with aging in many tissues [32, 
36, 65, 121, 122]. Despite decades of research on this topic, the collective results are 
mixed and some data indicate that oxidative damage with aging is tissue-dependent [27, 
34, 36, 123, 124]. One key point consistent across studies is the importance of damage to 
cells, whether that damage is a result of oxidation overload or lack of mechanisms to 
combat oxidation, such as attenuation of antioxidant defenses [28, 29, 35, 119, 125, 126]. 
This is often referred to as an imbalance in the oxidant-antioxidant ratio and is important 
not only in aging but also in many disease processes. There are two possible ways to 
negatively alter this ratio: 1) through increased free radical generation and/or 2) through 
decreased antioxidant response [126]. 
 
Increased free radical generation by mitochondria is associated with aging [22, 127, 128]. 
At the same time, plasticity of the antioxidant response is reduced [129, 130], resulting in 
tissue that is less able to up-regulate antioxidants to combat an oxidative insult. The 
phenomenon of elevated oxidative stress in conjunction with lack of antioxidants has 
been well demonstrated in the aging brain [131-133] and is a major contributor to many 
age-related neurodegenerative diseases. Due to the loss of function that results from age-
related diseases, the focus of aging research and the oxidative damage theory has shifted 
to identifying factors that contribute to promoting healthy aging (healthspan) rather than 
extending lifespan [32]. Healthspan can be equated to increasing the number of years that 
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normal physical activities are maintained. While longevity is important, the current 
public health perspective places greater importance on improving health in later years and 
reducing morbidity leading to mortality.  The research focus of this dissertation, to 
improve skeletal muscle function by better balancing oxidative stress with age, aligns 
with this public health goal.  
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1.7 Oxidative stress and damage in skeletal muscle 
 
Skeletal muscle is a highly metabolic tissue that produces and experiences high levels of 
oxidative stress [134, 135]. Mitochondria are a main source of ROS production in 
skeletal muscle, specifically the leak of superoxide from complexes one [136, 137] and 
three [138] in the electron transport chain [139-141]. However, NADPH oxidase (NOX) 
[135, 142, 143] and Xanthine Oxidase (XO) [144, 145] are additional sources of ROS 
production in muscle. Levels of oxidative stress fluctuate in skeletal muscle in relation to 
the levels of functional demand placed on the tissue. When muscle activity levels are 
high, such as that experienced during intense exercise, mitochondrial ATP production 
and therefore ROS production increase [146]. This has been demonstrated by numerous 
studies in adults [147, 148] and aged individuals [33, 149].   
 
Levels of ROS and antioxidant production are altered with aging even under conditions 
of normal use (i.e., not intensive exercise) [150] and as previously discussed, aging is 
hypothesized to alter the antioxidant response. Thus, interpretation of the effects of aging 
on the oxidant and antioxidant balance specifically in skeletal muscle is difficult. As 
such, global markers can be useful in addressing changes in oxidation that occur. One 
commonly utilized global marker is biopterin (BP), formed from the oxidation of 
tetrahydrobiopterin (BH4), an essential cofactor in the synthesis of a number of 
neurotransmitters including dopamine, norepinephrine, epinepherine, and serotonin. BH4 
also plays a crucial role in nitric oxide synthesis. BH4 can be synthesized through both 
the de novo and salvage/recycling pathways of several tissues including brain, spleen, 
liver, kidney and adrenal glands. The de novo pathway requires the enzymatic conversion 
of guanosine triphosphate (GTP), resulting in the formation of BH4. The 
salvage/recycling pathways utilize a series of enzymes that convert the by-products of 
BH4 utilization back to BH4 [151-156]. Biopterins cycle between dihydrobiopterin (BH2) 
and BH4 depending on oxidation state; however, under conditions of oxidative stress BH2 
can be non-enzymatically oxidized to BP providing an indication of oxidative status. 
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Additionally, BH4 serves as the catalyst for the production of nitric oxide (NOS); the role 
of BH4 in this enzymatic process is so critical that some research points to a deficiency of 
BH4, and thus of nitric oxide, as being a core contributor to the neurovascular dysfunction 
that is the hallmark of circulation-related diseases such as diabetes. Recent research into 
the role of BH4 in muscle function has provided some evidence to support that the decline 
in vasodilation of muscles that occurs with aging is in part due to limited BH4 availability 
[157-159] which in turn results in decreased NOS [160] and reduced exercise capacity 
[161]. Furthermore, it is suggested that reduced BH4 availability can result in uncoupling 
of NOS resulting in increased production super oxide [162].  
 
In addition to limitations in BH4 availability that occur with aging, it is hypothesized that 
there is an increase in irreversible oxidation of BH2 to biopterin (BP), due in part to 
increased ROS generation resulting from dis-regulation of NOS [163]. Specifically, low 
levels of BH4 are credited with uncoupling of eNOS which drives the system to produce 
superoxide radicals instead of nitric oxide [162, 164, 165]. Once BH4 is oxidized to BP, 
it is unable to participate in regulation of NOS activation. Thus, further reduction of the 
bioavailability of BH4 through this mechanism will drive the system to produce more free 
radicals (Figure 1). 
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1.8 Effects of estrogens on oxidative stress and damage 
 
Sex differences in oxidant production by mitochondria have been shown, and it is 
hypothesized that these differences are due to effects of estrogens [166-168]. Recent 
research supports a critical role for estradiol in managing energy metabolism of the 
mitochondria and overall mitochondrial health [38, 39, 106, 169]. Furthermore, cell 
susceptibility to stress [170] and damage to DNA from oxidative stress are higher in 
males than  females [171]. There is some evidence for the protective role of estrogens or 
estrogen-like compounds, against oxidative induced damage in muscle cells [18, 172-
174], endothelial cells [175], and other cells of mesenchymal lineage [176-179]. 
Specifically, estradiol has been shown to be protective against hydrogen peroxide-
induced oxidative damage in cultured muscle cells, but not much is known about the 
effects of estradiol on muscle fibers and skeletal muscle tissue in vivo [18]. 
 
The mechanisms through which estradiol is protective to non-reproductive tissues and 
cells, as well as the extent to which this protection is afforded with aging, are not fully 
understood. As discussed previously, estradiol can act through estrogen receptors (ERs) 
in a genomic fashion as well as through a non-genomic fashion via membrane receptors 
and direct activation of other molecules. The current evidence indicates protection against 
oxidation via ER-activated responses in adipose tissue [23], smooth muscle [180], and 
cardiac muscle [181]. Involvement of ERs in estradiol signaling is further substantiated 
by evidence of ER utilization for skeletal muscle regeneration [182-184] and metabolism 
[185-187]. The hypothesis that estradiol is acting primarily through ERα, as opposed to 
ERβ, is based on work by a previous member of our laboratory who reported that ERα is 
the most abundant ER in mouse skeletal muscle, has higher expression in fast-twitch than 
slow-twitch muscle, and is sensitive to changes in circulating levels of estradiol [37]. 
Recently a study was carried out on skeletal muscle specific ERα knockout mice that 
further supported this mechanism for estradiol in skeletal muscle, particularly as it relates 
to metabolism. Diminished muscle oxidative metabolism accompanied by muscle 
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dysfunction was observed in mice lacking ERα [38] suggestive of a role for estradiol in 
oxidative metabolism of skeletal muscle.   
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1.9 Effects of aging on antioxidants 
 
Changes in antioxidant levels with exercise and aging is a topic of considerable interest; 
however, most research has focused on intake of antioxidants such as Vitamin E or 
Vitamin C, and few have investigated the endogenous enzymatic antioxidants such as 
Glutathione or Superoxide Dismutase. As previously discussed, with aging the response 
of skeletal muscle to stress is blunted (i.e., muscle is less able to adapt to changing 
conditions with age). This is further evidenced by changes in the ability of skeletal 
muscle to adapt to exercise with aging. It is well known that exercise induces production 
of reactive oxygen species (ROS) and that healthy muscles adapt antioxidant defense 
systems to combat the increase in ROS. Specifically, exercise has been shown to up-
regulate superoxide dismutase, catalase and glutathione peroxidase [188-190].  
 
Early studies investigating endogenous antioxidants suggested a decline in antioxidants 
with aging [191-196]. More recently, studies investigating antioxidant levels in aged 
skeletal muscle have yielded conflicting results. For example, one study found no effect 
of aging on basal levels of antioxidants but when subjected to exercise, levels of 
glutathione and glutathione peroxidase increased [197] while another found decreased 
levels of glutathione content with aging and no response of the antioxidants to exercise 
[198] and in yet another study increases in manganese superoxide dismutase and catalase 
activity were observed concurrent with the age-induced increases in oxidative stress [31]. 
Studies focusing on the impact of aging on superoxide dismutase are easier to interpret. 
In male rodents, with aging there is a decline in expression of superoxide dismutase [199] 
these results are further corroborated by studies utilizing SOD1 knockout mice. These 
studies found that deletion of SOD1 in young mice resulted in a skeletal muscle 
contractile phenotype similar to that of aged mice [138, 200], suggesting that SOD1 is 
critical for the ability of muscle to adapt/neutralize reactive oxygen species following 
exercise [201, 202].  With aging, this adaptability in skeletal muscles following exercise 
is abolished [149, 203]. 
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Collectively, literature is in agreement on the importance of superoxide dismutase, 
catalase, and glutathione peroxidase on the function of aged skeletal muscle, but it 
remains to be determined how these levels are impacted by exercise with aging. Thus, a 
goal of this dissertation is to investigate the impact of aging on antioxidant levels in 
skeletal muscle following exercise. 
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1.10 Effects of estrogens on antioxidants 
 
A limited number of studies have investigated the impact of estrogens on antioxidants in 
skeletal muscle. Research in women during different phases of the menstrual cycle is 
contradictory with some studies reporting increased blood levels of antioxidants, 
specifically superoxide dismutases, following exercise when estrogen levels are high 
[204] and others reporting no impact of menstrual phase on antioxidants [205]. In cardiac 
muscle, estradiol deficiency results in low levels of glutathione peroxidase, catalase, and 
superoxide dismutase [206, 207]. Previous studies in female mouse skeletal muscle have 
found that regulation of several antioxidant genes is affected by estradiol [37]. Of 
particular interest were glutathione peroxidase 3 (Gpx3), glutathione Peroxidase 1 
(Gpx1), and NADPH Oxidase 4 (NOX4) as these antioxidants were known to be 
sensitive to aging and estradiol treatment. Further studies performed in cultured muscle 
cells, demonstrated that treatment with estradiol increases concentrations and activity of 
SOD2 [208], although the mechanism was not investigated. Taken together, these studies 
are suggestive of a role for estradiol in regulating antioxidant availability.  
 
The role of estradiol in regulation of antioxidants in skeletal muscle has been minimally 
investigated and the limited results warrant additional investigation to elucidate the 
effects of estradiol deprivation on not only oxidation in skeletal muscle, but also the 
mechanisms that underlay these changes (i.e., antioxidant regulation). The studies in this 
dissertation seek to further examine  the effects of estradiol deprivation on antioxidants, 
and additionally, to determine if this effect is maintained or altered with aging. 
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Chapter #2: Impacts of estradiol and aging on sub-maximal strength and power 
 
There is ample evidence for strength loss with aging; however, most studies have focused 
on males when investigating strength loss and the underlying mechanisms. Limited 
studies on strength loss with aging in women have demonstrated a beneficial effect of 
hormone-replacement therapy on maintaining muscle strength. But the variability in 
study design, time of therapy initiation, duration of therapy usage, and type of therapy 
employed make it difficult to come to consensus. Several studies have sought to 
investigate this further by utilizing rodent models, where estradiol levels and treatment 
can be better controlled. Most previous studies examining the effects of aging and 
hormones on female mouse muscle have utilized an ex vivo approach, with small 
hindlimb muscles, such as the soleus or extensor digitorus longus (EDL) muscle 
dissected from the animal. This approach has many advantages but is also limiting 
because a) it cannot accommodate larger muscles due to the limitation of oxygen 
diffusion to core fibers as the vasculature is disrupted when the muscle in removed from 
the animal b) the loss of other environmental factors delivered in the blood, c) contraction 
is initiated downstream of the neuromuscular junction so any involvement of that 
structure is not measured, and finally d) smaller muscles have less of a contribution to 
hindlimb strength and power so investigating larger, more functionally-relevant muscles 
and muscle groups is advantageous.  
Thus, the following studies employ an in vivo approach to muscle function testing which 
allows for testing the muscle in a more functionally relevant manner in an anesthetized 
mouse. The muscle is left in the native environment and rather than testing a single 
muscle, this approach allows for testing of a muscle group in the same manner as these 
muscles would be elicited by the mouse during normal ambulation. Also limiting in 
previous studies was the use of only adult ovariectomized mice, and not aged mice that 
had undergone the same treatment. To fully address the effects of ovarian hormones, and 
specifically estradiol, both adult and aged mice must be subjected to the same treatment 
and timeline. 
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The first study of this dissertation utilizes adult and aged female mice to ask the 
following questions: Given what is known about the effects of estradiol deprivation on 
maximal strength of skeletal muscle, what is the impact of ovariectomy on the more 
physiologically relevant measures of sub-maximal muscle strength and muscle power? 
Can replacement of estradiol counteract the effects of ovariectomy? Do aged mice 
respond similarly to treatment as adult mice? 
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Chapter 2: Impact of aging and ovarian hormones on skeletal muscle function 
 
Study #1 - Part A:  
 
Hypotheses –  
Ovariectomy will result in lower muscle power and submaximal torque generation in 
adult female mice compared to ovary-intact female mice, and treatment with estradiol 
will reverse these effects. Aged, ovarian senescent female mice will have lower muscle 
power and submaximal torque than adult mice. Ovariectomy in the aged, already ovarian 
hormone-deficient mice will not impact muscle contractility, but treatment with estradiol 
will return strength and power to levels observed in adult mice. 
 
Study design –  
Adult (4 month old, n=24) and aged (22 month old, n=28) female C57BL6 mice were 
obtained from the National Institute of Health Aging Colony. Vaginal cytology was 
performed for four consecutive days to confirm normal estrous cycling in adult mice and 
ovarian senescence in aged mice. Cellular markers of normal estrous cycling as well as 
those that accompany ovarian senescence are described in detail in the vaginal cytology 
methods section below. Adult and aged mice were randomly divided into three treatment 
groups: control, ovariectomy (OVX), and ovariectomy with 17β-estradiol treatment 
(OVX + E2). Mice in the control group were maintained in normal specific pathogen free 
(SPF) housing until time of testing and sacrifice. Mice in the OVX and OVX+E2 groups 
underwent bilateral ovariectomy as described in detail in the methods below.  17β-
estradiol treatment in the OVX+E2 group was initiated at time of ovariectomy and was 
accomplished via a subcutaneous implanted time-release pellet, as described in detail in 
the methods below. Vaginal cytology was once again performed in the OVX group for 4 
consecutive days to verify effectiveness of ovariectomy.  
 
Approximately 3 months after surgery (and hormone treatment), mice were anesthetized 
and in vivo muscle function of the posterior crural muscles was assayed. Maximal 
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isometric torque, submaximal isometric torque (via a torque-frequency protocol), and 
power (via a torque-velocity protocol), were measured as described in detail in the 
methods below. Following in vivo testing, muscles were harvested and stored at -80°C for 
further biochemical analysis to address oxidative stress questions in a subsequent study. 
Uteri were weighed as secondary confirmation of effectiveness of ovariectomy. 
 
Statistics –  
Statistical power calculations were used to determine ideal sample sizes for studies 
necessary to apply an alpha level of 0.05 with 80% power. Expected variability was 
determined from previous studies performed in our laboratory and the wider literature 
base. Data were analyzed using a two-way ANOVA (age x ovarian status). Since there 
were no statistically significant interactions, all p-values reported are main effects of age 
and ovarian status. For all statistically significant main effects of ovarian status, a Holm-
Sidak post-hoc test was implemented. All statistical calculations were performed on 
Sigma Stat statistical software. 
 
Methods – 
Often, adult mice are manipulated pharmacologically, genetically, or surgically to model 
aging. While those approaches can be useful tools and are often a necessity due to the 
difficulty in obtaining old mice and the time-consuming nature of aging the mice for a 
study, there are important limitations to consider and address. This is especially true 
when using young ovariectomized mice to study the effects of estradiol deprivation. The 
majority of studies that have been performed in attempt to elucidate the effects on 
skeletal muscle have deprived mice of hormones for 1-2 months. However, if we are truly 
attempting to investigate the effects of estradiol deprivation as it occurs in the context of 
aging, then the duration of deprivation becomes exceedingly important. Ovarian 
senescence occurs at 18-20 months of age in mice, though some reports suggest this may 
happen even earlier [14, 98-100, 209-213]. Therefore, by the time mice reach an age at 
which they are considered old (24 or 28+ months), they have been senescent for a 
minimum of 4-6 months. With this in mind, studies conducted in this dissertation using 
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adult hormone deprived mice have sought to investigate not only the effects of estradiol 
deprivation, but also the effects of duration of deprivation. 
 
Vaginal Cytology 
Vaginal cytology is important to track when studying females as estradiol and other 
ovarian-derived hormones can impact the outcome measures of a study if those measures 
are hormone sensitive. For this dissertation, cytology was an important tool that allowed 
mice to be studied at high and low levels of naturally circulating estradiol. Furthermore, it 
served to verify senescence of ovaries, when ovaries stop producing hormones similar to 
menopause in women, and also to confirm effectiveness of ovariectomy surgeries. 
 
Accounting for estrous cycle is often an overlooked aspect of female studies, yet can be 
highly informative when interpreting results. The estrous cycle is driven by changes in 
circulating hormone levels and as a main component of this dissertation is to investigate 
effects of estradiol deprivation it was critical to confirm that young adult ovarian-intact 
mice had normally circulating levels of estradiol. The vast majority of studies utilizing 
female rodents fail to report tracking of estrous cycle; this can be easily accomplished 
and is a tool that should be utilized by all female rodent studies moving forward when 
estradiol is implicated. Furthermore, because of the changing hormone levels in female 
rodents, most studies of aging muscle have used male rodents, as they do not need to 
account for fluctuating or declining hormone levels. While it is true that many biological 
variables likely are not affected, evidence from several studies demonstrate that muscle 
contractility can be affected by estradiol deficiency, at least after the hormone has been 
low for 4-8 weeks [4, 15, 104]. 
 
Vaginal cytology swabs were taken as follows to identify the estrous cycle phase of mice. 
A phosphate buffered saline wetted cotton swab was inserted approximately 1-2 mm into 
the vagina and rotated 360 degrees to acquire cells. Cells were then transferred from the 
cotton swab to a statically-charged microscope slide and stained in hematoxylin. Slides 
were rinsed and then visualized under a microscope at 5-10X magnification. Changes in 
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ovarian hormones drive the alterations in cell population that are observed. In short, the 
lowest level of estradiol is present at the metestrus and diestrus phases whereas the 
highest level of estradiol is present at the proestrus and estrus phases [209, 214]. The 
following cell features were used to identify cycle phase [100, 209, 215, 216]:  
 
Diestrus – cells are predominately leukocytes; nucleus is clearly visible and 
occupies the majority of cellular space; often accompanied by mucus (Figure 2A).  
Proestrus – cells are transitioning to estrus; cells are predominately nucleated 
epithelial cells; nucleus remains clearly visible but additional cytosol of cell 
surrounding nucleus is apparent (Figure 2B). 
Estrus – cells are predominately cornified epithelial cells; nucleus is no longer 
apparent and cytosolic volume occupies the majority of the cellular space; cells 
are well formed (Figure 2C).  
Metestrus – cells are transitioning to diestrus; cells are predominately collapsing 
epithelial cells; cells lose structure and beginning to fold onto one another, 
nucleus may begin to become apparent (Figure 2D).  
 
Following ovariectomy, when estradiol levels are low, estrous cycles will be absent and 
cytology will become consistent (Figure 2E). Similar lack of cycling will occur at the 
time of ovarian senescence, but cells will present differently from in which ovaries are 
removed. Aged mice will exhibit persistent vaginal cornification (PVC), in which densely 
packed, cornified epithelial cells and leukocytes will be present (Figure 2F). This can 
sometimes be confused for metestrus, but the key aspect that differentiates PVC is the 
lack of cycling. Thus, swabs must be taken on multiple consecutive days. 
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from#an#ovarian#senescent#aged#mouse.#
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Ovariectomy 
Ovariectomy was a critical tool for inducing a state of chronic estradiol deficiency in 
mice and was used in the majority of the studies in this dissertation. This procedure 
allows for estradiol deprivation to be studied, independent of aging. Furthermore, when 
combined with replacement of estradiol via an implanted hormone pellet, it allows for the 
targeting of estradiol by removing all other ovarian hormones (e.g., progesterone which is 
the other major female sex hormone produced by ovaries).  
 
Bilateral ovariectomy was performed as follows on anesthetized mice for the purpose of 
removing the main estradiol-producing tissue and invoking a state of estradiol deficiency. 
Mice were anesthetized under isoflurane 1-2% mixed with oxygen at 125-250 mL/min 
while lying on a heating pad at 37° to maintain body temperature for the duration of the 
surgical procedure. Due to their small body size, mice are unable to independently 
maintain body temperature while under anesthesia. As such, a heating pad must be 
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employed to prevent mice from becoming hypothermic. Mice were given ophthalmic 
ointment to maintain moisture to the eyes during anesthesia and a sub-cutaneous injection 
of slow-release analgesic buphrenorphine (0.1 mg/kg) to ease any discomfort or pain 
associated with the surgical procedure and healing of the incision site during the days 
following surgery. The surgical site was prepared by shaving the hair on the back just 
below the iliac crest down to the lower ribs followed by cleansing with betadine and 
ethanol to create an aseptic site for the skin incision. An incision, approximately 2 cm, 
was made down the spine, and the skin fascia teased back to expose the underlying 
muscle. The ovaries were accessed through two incisions made in the muscle layer of the 
abdomen. The ovaries were located and the uterine tubes cauterized to remove the 
ovarian tissue. Care was taken to avoid directly gripping the ovary with the forceps as 
this could release a small amount of ovarian tissue back into the abdominal cavity and 
impact effectiveness of the surgery as residual ovarian tissue can still produce hormone. 
The muscle layer was closed with 6-0 silk suture and the skin closed with steel wound 
clips [107]. The wound clips were later removed, once the skin had healed, 
approximately 7-10 days post surgery.   
 
Estradiol treatment 
In order to isolate the effects of estradiol from other ovarian hormones, following the 
ovariectomy procedure, an implanted slow-release 17-β estradiol pellet (Innovative 
Research of America, Sarasota, FL) was utilized. 17-β estradiol was the specific estrogen 
used for treatment, as it is the most bioavailable form of estradiol. The dose of estradiol 
chosen varied from one study to another, depending on the question to be addressed and 
tolerability of the hormone dose by the mouse. Previous studies have utilized 0.18mg, 60 
day slow release pellets in adult mice [14, 15, 217] which delivers approximately 3µg of 
estradiol per day, and 0.09mg, 60 day slow release pellets in aged mice which delivers 
approximately 1.5µg of estradiol per day. A lower dose is used for aged mice as studies 
report urinary retention when higher levels are used [17, 218].  
 
  31 
For studies performed in adult female mice (4-6 months of age), a dose of 0.18mg 
released over the course of 60 days was used. For studies investigating longer duration of 
hormone deprivation, a lower dose pellet of 0.135 mg released over 90 days was used. 
This lower does was chosen to help mitigate bladder problems that can arise from the 
longer treatment duration and to correspond with the dose given to aged mice in previous 
studies [17, 219-222]. Thus, adult and aged female mice with 3 months of hormone 
deprivation were implanted with the lower dose 90-day release pellet. Important to note is 
that the relative higher and lower doses of estradiol treatment used in the studies in this 
dissertation both result in physiological level of circulating hormone. 
 
In subsets of mice that underwent the ovariectomy procedure, estradiol was replaced 
through the use of a commercially available, slow-release estradiol pellet. While under 
anesthesia immediately following ovariectomy, the base of the neck was swabbed with 
betadine and the estradiol pellet implanted subcutaneously using a trochar at the base of 
the neck. This location was selected to help prevent the mouse scratching at the pellet and 
incision site during its normal grooming behaviors. The small incision site made by the 
trochar was sutured shut with 6-0 silk suture to ensure that the pellet did not become 
dislodged while the skin healed.  
 
In vivo skeletal muscle contractile testing   
A notable strength of the muscle physiology testing performed in this dissertation is the 
use of an in vivo approach (Figure 3). While studies investigating muscle strength ex vivo 
are more commonly found, and have the positive aspect of isolating the muscle from the 
environment, this can also be considered a weakness of testing only ex vivo. By utilizing 
an in vivo approach, the muscle is tested under native conditions and contributions from 
changes that may arise in vasculature, muscle innervation, neuromuscular junction, and 
membrane potential are observed in the muscle strength outcomes. 
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Figure 3: A) in vivo electrode positioning for 
recruitment of the posterior hindlimb muscles; 
B) Example tracing for posterior maximal 
isometric torque of an adult and aged female 
mouse.
 
For all in vivo testing protocols, mice were anesthetized with isofluorane (1-2% at oxygen 
flow rate of 100-200 mL/min), hair was removed from the anterior lower hind limb with 
Nair and the injury area aseptically prepared with betadine and ethanol. Ophthalmic 
ointment was applied to maintain moisture to the eyes while under anesthesia and mice 
were maintained on a heating pad at 37°C [107, 223]. Body temperature has a drastic 
impact on muscle performance, as muscles are critical to providing body heat through 
thermogenesis. Thus, a single degree drop in body temperature can drastically alter 
strength. 
 
For testing of the posterior crural muscles (gastrocnemious, plantaris, soleus muscles), it 
is not possible to isolate the tibial nerve, thus denervation of the common peroneal nerve 
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was performed to eliminate co-activation of the antagonist muscles (anterior crural 
muscles) and allow for stimulation of the sciatic nerve [224, 225]. Denervation was 
accomplished as follows: the left leg of the anesthetized mouse was stabilized and an 
incision, approximately 0.25 cm in length, was made over the lateral crural ligament of 
the knee joint. The underlying hamstring muscle was resected, and the common peroneal 
and tibial nerves exposed, just distal to the branching of these from the sciatic nerve. The 
common peroneal nerve was severed and a portion of the nerve removed to eliminate 
antagonistic contractions of the anterior crural msucles . The skin was then sutured shut 
with 6-0 silk suture to keep underlying tissues moist during muscle testing.  
 
Mice were positioned on their right side, with the left leg stabilized at the knee by a 
clamp and the left foot secured to a custom made foot plate attached to a servomotor that 
is attached to a force transducer (300B-LR; Aurora Scientific, Ontario, Canada). The foot 
and knee were secured so as to create a 90° angle at the knee and ankle joints thus 
aligning the tibial bone perpendicular to the foot plate. The servomotor can be moved 
through 40° range of motion about the ankle, 20° plantarflexion and 20° dorsiflexion. 
Muscle torque, force produced about the angle of the ankle, was measured by the force 
transducer. Platinum subdermal needle electrodes were placed to stimulate the sciatic 
nerve, for posterior testing. The needle electrodes were attached to a stimulator and 
stimulus isolation unit (E2-12, S28, and SIU5; Grass Telefactor, Warwick, RI). 
Stimulation parameters varied depending on the protocol, and are outline in the 
individual protocols below: 
1. Peak isometric torque 
The peak isometric torque protocol is used not only to measure maximal strength 
but also to identify optimal voltage for all subsequent in vivo protocols. Voltage 
was increased from 3 to 8 V, and optimal voltage was defined as the voltage at 
which torque ceased to increase. The stimulator was set to parameters of 150-ms 
contraction duration of 0.5-ms square-wave pulses delivered at a frequency of 250 
Hz.  
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2. Torque-frequency protocol 
The torque-frequency protocol is an important tool for identifying the effect of 
interventions (for the purpose of this dissertation those interventions are estradiol 
deficiency and age) on muscle excitability. While all other in vivo protocols 
stimulate at an optimal frequency to create maximal contractions, identified by 
previous studies, this protocol measures the torque produced across a range of 
stimulation frequencies. At low frequencies, multiple twitches of the muscle are 
observed and submaximal forces measured, as stimulation is not sufficient to 
cause fusion of twitches into tetanus. However, as frequency increases, twitches 
become more rapid and fuse to form the tetanic contractions and higher forces 
until complete fusion occurs – this is the optimal frequency.  
 
Data can be plotted as a percent of the maximal (or optimal) torque produced and 
shifts in the curve can be assessed. A leftward shift in the force-frequency curve 
indicates that lower frequencies are required to elicit the same percentage of 
maximal torque, or in other words the muscle is more excitable. A rightward shift 
indicates the opposite, that more stimulation is required to generate the same 
percent of maximal torque, a less excitable muscle. Another measure of muscle 
excitability is referred to as “Freq50”, this is the frequency required to elicit 50% 
of maximal torque. The sciatic nerve was stimulated with optimal voltage and 
torque was measured at frequencies of 10, 20, 30, 40, 60, 80, 100, 125, 150, 200, 
250, and 300 was measured. 
 
3. Torque-velocity (Power) protocol 
The torque-velocity protocol was a key tool to address the objectives of this 
dissertation. Power, the product of torque produced at a given velocity, is widely 
understudied, especially in rodent models. Yet, it is known to be a better predictor 
of function and mortality than other muscle measurements [226]. 
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During this protocol, the sciatic nerve was stimulated at 250 Hz while the leg was 
moved through the full range of motion at velocities of 100, 200, 400, 600, 800, 
1000, and 1200 m/s. Power was calculated from the torque output of the muscle 
group at each velocity. 
 
Results –  
Uterine mass confirmed successful ovariectomy and estradiol treatment, although low-
dose estradiol treatment did not return uterine masses to levels observed in control mice. 
Ovariectomy reduced uterine masses from 116.7 mg to 12.8 mg in adult mice and from 
114.3 mg to 26.3 mg in aged mice. Treatment with estradiol increased uterine masses to 
36.1 mg in adult mice and 56.4 mg in aged mice.   
 
There was no main effect of age on peak isometric torque of the posterior muscles 
(p=0.161), with both adult and aged mice producing approximately 14.5 N mm of 
torque. Ovarian hormone status also did not exhibit a main effect on peak isometric 
torque production (p=0.165; Figure 4).  
 
 
Figure 4: Age and ovarian hormone deprivation do not impact  
the peak isometric torque produced by the posterior crural  
muscles in female mice. Values are represented as mean ± SEM.  
 
 
To further probe the impact of aging and estradiol on muscle, sub-maximal torque was 
measured at stimulation frequencies ranging from 10-300 Hz. There was a main effect of 
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age on submaximal torque at stimulation frequencies of 60 Hz and lower (p ≤ 0.039) but 
not at stimulation frequencies of 80 Hz and higher (p ≥ 0.116). At frequencies of 10-60 
Hz, aged mice produced up to 20 % more torque than adult mice (post hoc p ≤ 0.039). 
There was no main effect of ovarian hormone status on sub-maximal torque production at 
any stimulation frequency 10-300 Hz (p ≥ 0.085; Figure 5).  
 
Another method of looking at sub-maximal torque, freq50, compares the stimulation 
frequency necessary to elicit 50% of the maximal torque. Consistent with the analyses of 
torque across the stimulation frequencies, there was a main effect of age on freq50 
(p=0.013). A stimulation frequency of 40.712 Hz was required in the aged mice while 
44.855 Hz was required in adult mice to generate 50% of maximal torque. There was no 
difference in freq50 among the hormone groups (p=0.697).  
 
*
*
*
*
*
 
Figure 5: Age but not ovarian hormone deprivation impacts sub-maximal torque production of 
posterior crural muscles in female mice at frequencies of stimulation below 80Hz. Values are 
represented as mean ± SEM. * indicates significant effect of age. 
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There was no main effect of age (p ≥ 0.174) or ovarian hormone status (p ≥ 0.542) on 
power production as calculated from torque produced at velocities ranging from 100-
1200 degrees/second (Figure 6). 
 
 
Figure 6: Age and ovarian hormone deprivation do not impact power production of posterior crural 
muscles in female mice. Values are represented as mean ± SEM. 
 
 
Conclusions –  
Removal of ovarian hormones by ovariectomy does not affect maximal strength, 
submaximal strength, or power of the posterior crural muscles in 6 or 24 month-old 
female mice. Furthermore, treatment of ovariectomized mice with 17-β estradiol for 10-
12 weeks does not impact posterior crural muscle strength or power in adult or aged 
female mice. Female mice aged 24 months do not demonstrate decrements in maximal 
strength or power compared to 6 month-old adult mice; however, at low stimulation 
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frequencies, posterior crural muscles of aged mice generate more torque than adult mice. 
This difference may reflect a shift in motor unit types.  
 
In general, results of this study do not support the hypotheses that muscle strength and 
power would decline with aging. As previously stated, female mice undergo ovarian 
senescence around 18-20 months of age. Thus the 24-month aged females used in this 
study had not been senescent for more than 6 months. Perhaps longer duration of ovarian 
hormone deficiency is necessary to elucidate the decrements in muscle function that have 
been previously demonstrated ex vivo. As longer duration of ovariectomy is not advisable 
in aged mice, an additional study was undertaken using adult female mice with a longer 
duration of ovarian hormone deficiency. 
 
 
 
 
 
 
 
  39 
Study #1 - Part B: 
 
Hypothesis –  
Muscle power and submaximal strength will decrease with an extended duration of 
ovarian hormone deprivation. 
 
Study Design –  
Female C57BL6 mice aged 3-4 months were obtained from the National Institute of 
Health Aging Colony and Jackson Laboratories. Mice were ovariectomized and 
maintained for 6 months (n=5) or 12 months (n=5) in a hormone deficient state. Two of 
the mice in the 12-month ovariectomy group had to be euthanized prior to the endpoint 
due to health concerns. For comparison, ovariectomized mice from part A (n=10) were 
included in the analysis (3 month OVX). This was done to minimize the number of mice 
needed for the additional investigation. Vaginal cytology was performed for 4 
consecutive days following recovery from surgery to verify effectiveness of ovariectomy.  
 
As described in detail in the methods section of Study #1- part A, mice were anesthetized 
and in vivo muscle function was assayed. Maximal isometric torque, submaximal 
isometric torque (via torque frequency), and power (via torque velocity) of the posterior 
crural muscles were measured. Following in vivo testing, muscles were harvested and 
stored at -80°C for further biochemical analysis to address oxidative stress questions in a 
subsequent study. Uteri were weighed as secondary confirmation of effectiveness of 
ovariectomy. 
 
Statistics –  
Statistical power calculations were used to determine ideal sample sizes for studies 
necessary to apply an alpha level of 0.05 with 80% power. Expected variability was 
determined from previous studies performed in our lab and the wider literature base. Data 
were analyzed using a one-way ANOVA and a Holm-Sidak post-hoc test was 
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implemented to determine significant differences between groups. All statistical 
calculations were performed on Sigma Stat statistical software. 
 
Results –  
There was no difference between 3 months, 6 months, and 12 months of ovarian hormone 
deficiency on uterine mass, maximal isometric torque, sub-maximal isometric torque, or 
power (Table 1).  
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Parameter 3 month OVX 
(n=10)
6 month OVX 
(n=5)
12 month OVX 
(n=3)
one-way ANOVA 
p-value
Uterine mass (mg) 12.8 (3.3) 23.0 (8.9) 24.3 (10.1) 0.011
Peak isometric 
troque (Nmm) 14.2 (1.1) 15.2 (0.4) 13.9 (0.7) 0.140
Isometric torque  
(Nmm)  
Frequency:   10 Hz 3.1 (0.5) 3.4 (0.4) 3.0 (0.5) 0.417
20 Hz 3.4 (0.6) 3.8 (0.4) 3.6 (0.5) 0.335
30 Hz 4.2 (0.9) 4.8 (0.4) 4.8 (0.7) 0.316
 40 Hz 5.6 (1.4) 6.4 (0.9) 6.6 (1.0) 0.372
60 Hz 9.2 (1.6) 10.3 (1.1) 10.8 (1.2) 0.183
80 Hz 12.0 (1.3) 13.5 (0.9) 12.6 (0.7) 0.062
100 Hz 13.0 (1.2) 14.2 (0.9) 13.3 (0.6) 0.165
125 Hz 13.4 (1.2) 14.5 (0.8) 13.5 (1.0) 0.224
150 Hz 13.6 (1.3) 14.6 (0.8) 13.7 (0.8) 0.239
200 Hz 13.5 (1.3) 14.5 (0.9) 13.4 (1.0) 0.292
250 Hz 13.2 (1.3) 14.0 (0.9) 13.0 (1.0) 0.393
300 Hz 12.7 (1.2) 13.3 (0.8) 12.4 (1.0) 0.488
Power (mW) 
Velocity: 1200 m/s 22.4 (9.5) 32.6 (14.5) 35.8 (22.3) 0.217
1000 m/s 32.1 (9.9) 38.7 (14.9) 36.8 (15.4) 0.600
800 m/s 41.4 (11.3) 47.8 (12.2) 40.9 (3.5) 0.534
600 m/s 48.7 (11.3) 54.6 (8.6) 45.9 (4.6) 0.439
400 m/s 50.1 (8.8) 54.4 (5.5) 48.0 (5.3) 0.472
200 m/s 39.5 (4.7) 40.9 (2.8) 38.6 (3.5) 0.718
100 m/s 24.5 (2.4) 22.9 (3.6) 24.2 (2.2) 0.584  
Table 1: Posterior muscle performance measures and uterine mass from female mice 
ovariectomized for 3, 6, or 12 months. Values are represented as Mean (SEM). 
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Conclusions –  
The duration of ovarian hormone deficiency does not appear to impact muscle function in 
adult female mice. However, it was not possible to include aged mice in this study, due to 
the difficulty of obtaining aged mice and successfully maintaining them for 6-12 months 
after ovariectomy. Therefore, it cannot be assumed that these results translate to aged 
female mice. Research in C57BL6/J male mice has shown that age-related strength loss 
and power deficits are not drastic until 28 months of age [56, 81-83]. Because the aged 
mice used in the first part of this study were only 24 months old, it is possible that they 
were not old enough to see drastic impacts of aging on skeletal muscle. Previous work by 
our laboratory in female rodents has focused on mice that are 28 months of age [17], as 
such it was unknown if at 24 months these mice would exhibit age-related changes in 
skeletal muscle. Additionally, by 28 months of age mice will have been ovarian senescent 
for a minimum of 6-8 months, thus further clarifying the impact of a longer duration of 
hormone deficiency in aged mice. It appears that at 24 months of age, female mice do not 
exhibit the strength or power loss associated with aging. To further probe the impact of 
aging on muscle function, an additional study was undertaken using 28-month-old female 
mice. 
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Study #1 - Part C:  
 
Hypothesis –  
Aging beyond 24 months will result in lower muscle power and submaximal strength. 
 
Study Design –  
Female C57BL6 mice aged 28 months (n=8) were obtained from the National Institute of 
Health Aging Colony and Jackson Laboratories. For comparison, control mice aged 6 
months (n=6) and 24 months (n=8) from part A were included in the analysis. This was 
done to minimize the number of mice needed for the additional investigation and because 
of the limited availability of and cost to house aged mice. Vaginal cytology was 
performed for 4 consecutive days to verify normal estrous cycling in 6-month-old mice 
and ovarian senescence in 24 and 28-month-old mice. 
 
As described in detail in the methods section of Study #1- part A, mice were anesthetized 
and in vivo muscle function was assayed. Maximal isometric torque, submaximal 
isometric torque (via torque frequency), and power (via torque velocity) of the posterior 
crural muscles were measured. Following in vivo testing, muscles were harvested and 
stored at -80°C for further biochemical analysis to address oxidative stress questions in a 
subsequent study.  
 
Statistics –  
Statistical power calculations were used to determine ideal sample sizes for studies 
necessary to apply an alpha level of 0.05 with 80% power. Expected variability was 
determined from previous studies performed in our lab and the wider literature base. Data 
were analyzed using a one-way ANOVA and a Holm-Sidak post-hoc test was 
implemented to determine significant differences between groups. All statistical 
calculations were performed on Sigma Stat statistical software. 
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Results –  
There was no main effect of aging on maximal isometric torque of the posterior crural 
muscles (p=0.131, Figure 7).  
 
Figure 7: Age does not impact peak torque  
produced by posterior crural muscles in female  
mice. Values are represented as mean ± SEM. 
 
There was no main effect of aging on sub-maximal torque (p ≥ 0.050, Figure 8). 
 
 
Figure 8: Age does not impact sub-maximal torque produced by posterior crural muscles in 
female mice. Values are represented as mean ± SEM. 
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There was a main effect of aging on torque produced while the muscle was being 
shortened at velocities of 100 - 1000 m/s (p ≤ 0.043). Female mice aged to 28 produced 
23 – 46 % less torque than 6 month or 24 month-old mice (post-hoc p ≤ 0.029, Figure 9). 
 
 
Figure 9: Posterior crural muscles of 28 month-old female mice produce less torque at velocities 
≤ 1000 m/s compared to 6 month and 24 month-old female mice. Values are represented as 
mean ± SEM. * indicates significantly different from 6 month and 24 month old mice. 
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There was a main effect of aging on power production at velocities of 1000 m/s and 
slower (p ≤ 0.043). Female mice aged to 28 months have lower power than 6 month or 24 
month-old mice (post-hoc p ≤ 0.029, Figure 10). 
*
*
*
*
*
*
 
Figure 10: Posterior crural muscles of 28 month-old female mice produce less power at velocities 
≤ 1000 m/s compared to 6 month and 24 month-old female mice. Values are represented as 
mean ± SEM. * indicates significantly different from 6 month and 24 month old mice. 
 
Conclusions –  
Aging to 28 months does not impact maximal or submaximal strength of the posterior 
crural muscles in female mice. This is in contrast to the results of part A, where 24-
month-old mice exhibited higher submaximal strength at stimulation frequencies below 
80Hz. However, in this study 28 month old mice produced less torque during 
contractions performed at velocities up to 1000 m/s. This resulted in lower power 
production of posterior crural muscles of 28-month-old females compared to 6 and 24-
month-old females. These results are suggestive of an intrinsic difference in the 
contractile apparatus of muscles from 28-month-old mice that is not observed in 24-
month-old mice. One possible explanation is that by 28 months of age, mice have been in 
a state of ovarian senescence for at least 6 months. Perhaps the differences observed 
between mice at 24 and 28 months of age result from the longer duration of hormone 
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deficiency in the older mice. Although longer duration of ovariectomy did not result in 
strength or power deficits in adult mice, perhaps low levels of ovarian hormones is of 
greater consequence to muscle function when combined with aging. A second possible 
explanation is that key aging-related changes in muscle may occur between 24 and 28 
months of age, although this remains to be verified. Collectively, the results gleaned from 
28-month-old mice provide valuable insight into changes in the ability of skeletal muscle 
to perform at velocity that occurs with aging in females. 
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Chapter Discussion –   
 
Study #1 sought to address the impact of ovariectomy on the more physiologically 
relevant measures of sub-maximal muscle strength and muscle power, determine to what 
extent estradiol is involved in ovariectomy-induced alterations in muscle function, and to 
identify to what extent aging effects occur independent of hormone-driven alterations. 
The results of study #1 indicate an estradiol-independent effect of aging on skeletal 
muscle power. These results are in agreement with the literature in male rodents that 
demonstrate a loss in skeletal muscle function by 28 months of age [81, 82, 227, 228]. 
Furthermore, the results of the present study suggest that deprivation of ovarian 
hormones may not be the driving cause for loss of muscle power. Previous studies 
utilizing aging female rodents investigated muscle strength ex vivo [4, 17, 229]. There are 
several differences between this study and previous studies done by our laboratory, 
perhaps the most important of which is the choice of the posterior crural muscles. The 
majority of the previous investigations into the effects of estradiol on muscle function 
utilized the anterior crural muscles. The posterior muscles were chosen for investigation 
due to the larger contribution of these muscles the rodent ambulation as well as the more 
mixed fiber composition of this compartment compared to the anterior.  
 
The results of study #1 did not support as drastic of an age-related strength loss as would 
be suggested by the literature in male rodents [81, 82, 227, 228] and further supports that 
males and females have different responses to aging. As previously discussed in the 
literature review, results from human literature would suggest that females would be 
more impacted than males, such that females would have lower strength with aging 
compared to age-matched male counterparts. One of the reasons behind this hypothesis is 
the loss of ovarian hormones that are thought to occur following ovarian senescence. 
However, recent research has shown that in contrast to our beliefs, estradiol levels may 
actually elevate at the time of ovarian senescence, rather than decline. If this is in fact the 
case, that the 24 and 28-month-old mice have high levels of estradiol, then the impact of 
hormones cannot be completely ruled out.  
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Overall, the results of study #1 demonstrate an impact of age on muscle function. 
Previous studies have supported a role of estradiol in muscle function as well, even 
though that is not corroborated by the results of this study. The underlying causes of the 
decline in function are not well understood. The strongest support comes from research 
suggestive of alterations in the binding of myosin. Evidence for oxidative changes in the 
contractile proteins of muscle, while not yet thoroughly investigated, is promising. The 
impact of aging on oxidative changes in contractile and non-contractile proteins of 
skeletal muscle is minimal, and merits further consideration. Initial studies in male 
rodents have identified changes in myosin structure [60, 62, 230] that impact its ability to 
produce force. However, studies investigating this in the context of females and with the 
impact of ovarian hormones have yet to be conducted. In order to elucidate the impact of 
aging and estradiol on oxidative stress and damage globally as well as at the level of the 
skeletal muscle proteins, additional studies were undertaken.  
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Chapter #3: Mechanism of aging and estradiol-related changes in skeletal muscle 
contractile function – alterations in oxidative damage 
 
Studies investigating the effects of aging on skeletal muscle oxidation in females are few. 
Aging has been shown to result in oxidative alterations to contractile proteins, such as 
myosin [62, 65, 230-232], that impacts the muscle’s ability to form cross-bridges 
necessary for muscle contraction. However, as with most aging research, the bulk of this 
work has been completed in males. And as demonstrated in other work investigating age-
related alterations in skeletal muscle in both males and females, there are sex differences 
in some aspects of aging [63, 233-241]. Thus, it is possible that sex-differences in 
oxidation of skeletal muscle occur and due to the disparate effects of aging on muscle 
strength in males versus females, investigation of sex differences is vital. The following 
studies seek to determine not only the sex-differences present in skeletal muscle 
oxidation but also the impact of ovarian hormone deprivation in adult and aged female 
mice. Other research in rodents indicates alterations in oxidative stress under aging and 
disease conditions in males. Questions that will be answered in the next serious of studies 
are: Are there changes in global oxidative stress levels induced by ovarian hormone 
deprivation and aging in females? Is there oxidative damage sustained by the contractile 
proteins following exercise in aged, ovarian senescent female mice?  
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Study #2 – Part A: 
 
Hypothesis –  
Levels of global oxidative stress in female mouse muscle will increase with age. 
 
Study Design –  
Urine samples were non-invasively collected from female C57BL6 mice aged 4 months 
(n = 10), 14 months (n =8), and 28 months (n = 8). Mice were obtained from the National 
Institute of Health Aging Colony and Jackson Laboratories, and were utilized for other 
studies reported in this dissertation. Levels of urinary biopterin, a marker of global 
oxidative stress, were measured and normalized to urinary creatinine levels as described 
in the methods below, with the exception that samples from 14 and 28-month-old mice 
were pooled with another mouse from their respective age groups due to smaller volume 
of urine collection. 
 
Statistics –   
Data were analyzed using a one-way ANOVA and a Holm-Sidak post-hoc test was 
implemented to determine significant differences among groups. All statistical 
calculations were performed on Sigma Stat statistical software. 
 
Methods –  
 
High Performance Liquid Chromatography – Biopterin Quantification  
High Performance Liquid Chromatography (HPLC) was used to quantify biopterin (BP) 
and total biopterin (BP+BH2+BH4) in urine from mice. Biopterin (Neopterin in humans) 
is the non-enzymatic oxidation product of BH2 that has been used as an indicator of 
oxidative stress in several disease states in both mice and humans [242-244]. Thus, 
urinary biopterin can be used to monitor perturbations in systemic oxidative status in 
response to various stimuli/stressors. Additionally, because BH4 is an essential co-factor 
in the synthesis of nitric oxide (NO), serotonin, dopamine and epinephrine, urinary 
  52 
quantification of total biopterin provides information regarding several necessary 
biosynthetic pathways. In this dissertation, urinary biopterin and total biopterin were 
measured as indicators of global oxidative stress and  nitric oxide availability, 
respectively, with estradiol deprivation and aging.  
 
To collect urine, mice were restrained and their bladders gently milked. Urine was 
collected in a microcentrifuge tube and stored at -20° until time of analysis. Sample 
preparation and analysis were completed according to the methods of Lindsay et al [245].  
Samples were thawed on ice and diluted 1:50 in 20mM Ammonium Phosphate, pH 2.5. 
For total biopterin analysis, 100 µL of diluted sample was aliquoted into a separate 
microcentrifuge tube. Twenty microliters of acidic iodide (5.4 % I2/10.8 % KI in 1 M 
HCl) was added to the sample to oxidatively convert BH2 and BH4 to biopterin. 
Following addition of the acidic iodine, samples were incubated for 15 minutes at room 
temperature in the dark, to avoid oxidative loss by UV.  Following incubation, 10 µL of 
0.6 M ascorbic acid was added to reduce the tri-iodine and 100 µL was transferred to an 
HPLC vial for analysis (Chromtech, MN, USA). Untreated diluted urine, biopterin 
standard (1 µM concentration) and creatinine standard (100 µM concentration) were also 
loaded into HPLC vials and analyzed by strong cation exchange (SCX) chromatography 
on a Shimadzu i-series 2030C with UV detector and autosampler, RF-20A florescence 
detector and on-line degasser with a 20 mM ammonium phosphate pH 2.5 mobile phase 
pumped isocratically at 1 mL/min. Samples were maintained at 4°C via the HPLC 
cooling unit and separated based on positive charge using a Luna 5 µm SCX 100 Å, 250 
x 4.6 mm column (Phenomenex, CA, USA). Biopterin was detected at 353 nm excitation 
and 428 nm emission and creatinine at its natural absorbance of 234 nm. The 
concentration and identity of biopterin and creatinine were compared to their 
corresponding standard (freshly prepared each day and spaced evenly throughout each 
analytical run) and quantified by peak area using the software Shimadzu Class VP. 
Biopterin and total biopterin were normalized to creatinine and presented as mmol/mol to 
account for the individual variation in mouse hydration status that can significantly 
influence urinary metabolite concentrations [246]. 
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Results –  
There was no main effect of aging on urinary biopterin levels (p = 0.056). Female mice of 
all ages studied had biopterin levels between 0.6 and 1.2 mmol/mol creatine (Figure 11). 
 
Figure 11: Aging does not impact levels of urinary biopterin.  
Values are expressed as Mean ± SEM. 
 
There was a main effect of aging on levels of total biopterin in the urine (p<0.001). 
Female mice aged 14 and 28 months had up to 67% higher levels of total biopterin than 4 
month old mice (post-hoc p ≤ 0.002, Figure 12). 
*	*	
 
Figure 12: Aging results in increased levels of total biopterin  
in the urine of female mice. *indicates significantly different from  
4 month old mice. Values are expressed as Mean ± SEM. 
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There was also a main effect of aging on the ratio of biopterin (BP) to total biopterin (p < 
0.001). Female mice aged 14 months had 62% lower BP:total BP than 4 month old mice 
(post hoc p ≤ 0.022); however, by 28 months of age the ratio has rebounded to only 29% 
lower than 4 month old mice (post hoc p ≤ 0.014, Figure 13). 
†
*	
*	
 
Figure 13: Aging results in a decreased ration of urinary biopterin to  
total biopterin (BP:total BP). * indicates significantly different from  
4-month mice. † indicates significantly different from 14 month mice.  
Values are expressed Mean ± SEM. 
 
 
Conclusions –  
Aging resulted in increased total biopterin; however aging to 28 months did not alter 
levels of urinary biopterin, a measure of global oxidative stress. As a result, the ratio of 
urinary biopterin to total biopterin was low in mice aged 14 months compared to 4-
month-old mice but that ratio partially rebounded by 28 months of age. The alteration in 
the ratio was driven by the increase in total biopterin and not a decrease in urinary 
biopterin. Levels of oxidative stress, as measured through oxidation of BH2 to BP, appear 
to be less sensitive to aging than synthesis of BH4. This indicates that with aging there is 
more de novo synthesis of BH4, indicative of potential changes in NOS regulation. These 
results are further strengthened by results of previous studies showing increases in nitric 
oxide levels in skeletal muscle with aging [247]. The changes observed with aging in 
females beg the question of hormone-dependent effects, that is, might the differences be 
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due to ovarian senescence and the lack of estradiol production rather than, or in addition 
to, aging. To address the impact of ovarian hormone deficiency, an additional study was 
carried out with mice that had undergone ovariectomy. 
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Study #2 – Part B: 
 
Hypothesis –  
Levels of global oxidative stress in female mice will increase with ovarian hormone 
deficiency. 
 
Study Design – 
Urine was collected non-invasively from multiple groups of ovariectomized female mice 
used in study #1 – part B prior to in vivo testing and tissue harvest. Urine was collected 
from 3 groups of mice: 1 month (n = 5), 5 months (n = 7), or 10 months (n=4) following 
ovariectomy. Samples were assayed for urinary biopterin, a marker of oxidative stress, 
and normalized to urinary creatinine levels, as described in the methods of Study #2 – 
Part A. Urine from 6 month old control, ovary-intact females used in Study #2 – part A 
was used for comparison.  
 
Statistics –   
Data were analyzed using a one-way ANOVA and a Holm-Sidak post-hoc test was 
implemented to determine significant differences between groups. All statistical 
calculations were performed on Sigma Stat statistical software. 
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Results –  
There was a main effect of ovarian hormone deficiency on levels of urinary biopterin (p = 
0.005) in groups of mice that had been ovariectomized for 1, 5, or 10 months. Levels of 
biopterin were 62% lower in adult female mice following 5 months of ovariectomy 
compared to control (post hoc p = 0.012; Figure 14). 
 
Figure 14: Ovariectomy resulted in lower levels of urinary biopterin  
at 5 months post surgery. * indicates significantly different from control.  
Values are expressed as Mean ± SEM. 
 
There was a main effect of ovariectomy on levels of total biopterin (p < 0.001). Levels of 
total biopterin increased by more than 50% in all groups of ovariectomized mice (1, 5, 
and 10 months) compared to ovary-intact mice (p < 0.001; Figure 15). 
 
Figure 15: Ovariectomy resulted in higher levels of total biopterin  
compared to control female mice. * indicates significantly different  
from control. Values are expressed as Mean ± SEM. 
 
* 
* * * 
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There was a main effect of ovariectomy on the ratio of urinary biopterin to total biopterin 
(p < 0.001). In groups of mice that had been ovariectomized for 1, 5, or 10 months, the 
ratio was lower than that of control, ovary-intact mice (p < 0.001; Figure 16). 
 
Figure 16: Ovariectomy resulted in a lower ratio of urinary biopterin to  
total biopterin compared to control female mice. * indicates significantly  
different from control. Values are expressed as Mean ± SEM. 
 
 
Conclusions –  
Levels of urinary biopterin were lower in mice that had been ovariectomized for 5 
months. Levels of total biopterin were increased with ovariectomy, regardless of the 
duration of hormone deficiency.  The magnitude of increase was similar to that observed 
with aging. Furthermore, similar to the aged mice, the ratio of urinary biopterin to total 
biopterin was lower in ovariectomized mice compared to control. Once again, the change 
in the ratio was driven more so by the increase in the BH4 synthesis and less so by the 
alterations in urinary biopterin. However, it remains to be determined if the changes 
observed with aging are the result of hormonal changes or are driven independently by 
aging. Additional studies with aged mice of varying hormonal status would be necessary 
to identify hormone-independent effects of aging.  Similar magnitude of increase in de 
novo synthesis is observed in ovariectomized mice as what was found in study #2 – part 
A for aged mice. Collectively, these results indicate that global levels of oxidation are not 
drastically altered by removal of ovarian hormones.  
 
* * * 
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Previous research has indicated that tissue-specific oxidative damage occurs with aging 
and that oxidative modifications to contractile proteins of muscle may impact strength 
[62, 248-254]. Although changes in global oxidative stress are important to consider and 
can help inform what may be occurring in the muscle, direct measurement of oxidative 
changes to proteins in the skeletal muscle is necessary to further elucidate the 
mechanisms through which muscle function can be impacted. To further probe the 
influence of ovarian hormones on oxidative damage to skeletal muscle proteins, 
subsequent studies were carried out on male and female rodents. It is suggested that the 
response to exercise is a better measure of age-related changes than baseline alterations 
[149, 203, 255-257]. As such, studies were undertaken on male and female mice to 
identify the extent to which contractile and non-contractile proteins are oxidatively 
damaged following exercise. These studies address the following questions: Are there sex 
differences in oxidative damage to skeletal muscle with aging? Are contractile proteins or 
non-contractile proteins, such as cytosolic/mitochondrial/membrane proteins, more 
affected? 
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Study #3 – Part A: 
 
Hypothesis –  
Oxidative damage to skeletal muscle will be lower in adult females compared to males; 
however, with aging oxidative damage will increase greatly in females but not males such 
that aged females will have greater oxidative damage than aged males. Furthermore, 
levels of oxidative damage will be greater in the contractile proteins than in the 
cytosolic/mitochondrial/membrane proteins. 
 
Study Design –  
Male and Female C57BL6 mice aged 4 months (n = 4 of each sex) and 28 months (n = 5 
of each sex) were obtained from the National Institute of Health Aging Colony. Mice 
were anesthetized and subjected to in vivo electrically stimulated muscle contractions of 
the left hindlimb muscles, as described in Study #1 – part A. Following the bout of in 
vivo exercise, mice were injected with Sodium Pentobarbital (100 mg/kg). Gastrocnemius 
muscles were excised approximately 30 minutes following the completion of the exercise 
bout. Muscles were flash frozen in liquid nitrogen and stored at -80°C prior to use for 
oxidative damage assays. The medial head of the frozen gastrocnemius muscle that had 
undergone the exercise protocol (left leg) was homogenized, fractionated, and assayed for 
oxidized proteins using the biotin hydrazide marker, as described in detail in the methods 
below. 
 
Statistics –  
Because expected variability was unknown at the time of the study, group sizes were 
determined based on what is commonly seen in the literature. Data were analyzed using a 
two-way ANOVA (age x sex). Since there were no statistically significant interactions, 
all p-values reported are main effects of age and sex. All statistical calculations were 
performed on Sigma Stat statistical software. 
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Methods –  
 
Western Blots  
Careful preparation of samples was necessary to avoid inducing oxidative modifications 
that can easily occur during the homogenization procedure. To avoid such oxidation, 
muscles were immediately frozen in liquid nitrogen after harvesting from the mouse and 
were stored at -80 oC until processed further. During all steps of the homogenization 
samples remained frozen as detailed below. Immediately after homogenization, muscles 
were transferred to a solution containing 20% trichloroacetic acid. The low pH prevents 
oxidation but is not so low as to induce other biochemical changes [258, 259]. 
 
Western blots were a vital tool for the studies of this dissertation addressing the cellular 
changes to muscle resulting from estradiol deprivation and aging. The use of western 
blots allowed quantification of muscle specific oxidative damage as well as quantification 
of antioxidant proteins of interest. Oxidative modifications are easily induced with 
traditional methods of sample preparation and as such diligent work went into developing 
techniques to minimize the impact of homogenization and sample preparation on the 
outcome measures of interest. Precise and careful sample preparation was developed and 
the final procedures for this sample preparation are as follows. 
 
Muscle homogenization 
At the time of sacrifice, gastrocnemious muscles were snap frozen in liquid nitrogen and 
stored at -80°C until time of assay, at which time muscles were homogenized in a frozen 
state as follows: a mortar and pestle were cooled with liquid nitrogen so that samples 
would remain frozen during the entire homogenization process. The frozen muscle was 
added to liquid nitrogen in the mortar and was ground into a frozen powder. Liquid 
nitrogen was added during the process and the muscle was never allowed to thaw. The 
frozen muscle powder was transferred to a microcentrifuge tube containing 1 mL of a 
homogenization buffer consisting of 1x phosphate buffered saline (PBS) with 1% sodium 
dodecyl sulfate (SDS; detergent) and 20% trichloroacetic acid (TCA). The acid 
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concentration of 20% has been shown sufficient to inhibit oxidation of proteins, but not 
so high as to induce other molecular changes to proteins. Muscle powder was vortexed in 
the buffer to ensure exposure to the acid, and then stored at -20°C.  
 
Once all samples had been homogenized, it was necessary to remove the acid in order to 
perform the fractionation and enrichment of sample required for Western Blots, as the 
proteins will precipitate to some extent in the 20% acid solution. Acid was removed via a 
methanol precipitation; ice cold methanol was added to samples, which were then 
vortexed and frozen at -20°C for no less than 2 hours in order to precipitate the proteins. 
Samples were spun in a refrigerated 4°C centrifuge at >20,000g to pellet out all proteins. 
The supernatant was discarded and a pipette was used to remove any remaining liquid. 
Pellets were gently washed and re-spun to remove any remaining traces of acid. Pellets 
air-dried for 5 minutes prior to re-suspension in 1x PBS with 1% SDS buffer. To re-
suspend pellets, it was necessary to sonicate the samples at 4°C using 1-2 second bursts 
for a total of 30-45 seconds per sample. 
 
Following re-suspension, samples were spun at 1000g for 15 minutes to precipitate out 
the myofibrillar and nuclear fraction (here onward referred to as the myofibrillar fraction) 
[260]. The supernatant, which contains the cytosolic and membrane fraction (here 
onward referred to as the cytosolic fraction), was pipetted off and saved on ice in a new 
microcentrifuge tube. The myofibrillar fraction pellet was re-suspended in 1x PBS with 
1% SDS via 30 seconds of vortexing, and saved on ice. Protein concentrations of all 
samples were measured on a nano-drop spectrometer. A 100 uL portion of each sample 
was diluted to a protein concentration of 2 mg/mL and 6x Laemmli sample buffer was 
added to help stabilize the proteins, and frozen at -20°C. Remaining sample volume was 
stored at -80°C. At the time of western blot analysis, fractions were assayed for proteins 
specific to each fraction (e.g., myosin and GAPDH) to ensure successful fractionation. 
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Oxidative damage blot and gel 
Remaining undiluted homogenate samples were thawed on ice, a 200 uL aliquot was 
precipitated using methanol, as previously described, fractionated (to allow for separate 
analysis of oxidation in myofibrillar and cytosolic proteins) and re-suspended in a biotin 
hydrazide coupling buffer with phosphatase inhibitors, protease inhibitors, and SDS. 
Samples were treated with biotin hydrazde to a final concentration of 05.mM and 
incubated at room temperature for 2 hours while agitated, as adapted from Grimsrud et al 
[258]. A set of negative controls, not treated with biotin hydrazide, was also run. 
Following incubation, Lamelli sample buffer was added and samples were heated at 95C 
prior to loading on a 10% SDS-PAGE (electrophoresis) gel. 10uL of protein was loaded 
for each sample. Duplicate gels were run at 150V for 60 minutes at 4C and one set of gels 
subsequently transferred to PVDF membranes. The remaining set of gels was stained 
with coomassie for measurement of total protein.  
 
Following overnight transfer to PVDF membranes at 30V and 4C, membranes were 
blocked with PBS-based Odyssey blocking buffer diluted 1:1 with PBS for 1 hour at 
room temp, rinsed with PBST, and incubated with IR800-conjugated Streptavidin 
(1:10,000) in PBST. Membranes were rinsed in 4x15min in PBST. Membranes and 
coomassie stained gels were then imaged on the LICOR 800 channel and analyzed for 
sample signal of the entire lane. Oxidized protein, as identified by IR800-streptavidin tag, 
was normalized to total protein, as identified by coomassie gel (Figure 17). 
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Figure 17: A) Biotin-Hydrazide tagged protein 
carbonylation blot and B) SDS-page total protein gel with 
positive (oxidized) and negative controls (non-oxidized)
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Results –  
There was a main effect of sex (p = 0.003); female mice had higher levels of oxidized 
cytosolic proteins in gastrocnemius muscle than male mice following exercise. There was 
no effect of age on levels of oxidized cytosolic proteins (p = 0.184, Figure 18). 
†
†
 
Figure 18: Oxidation of cytosolic proteins in the gastrocnemius  
muscle was higher in female than in males. Values are expressed  
as Mean ± SEM. † Indicates significantly different from male at same age. 
 
There was no effect of sex the on the oxidation of myofibrillar proteins of the 
gastrocnemius muscle (p = 0.630). However, there was a main effect of age (p = 0.001). 
Aged mice had approximately 45% less oxidation than adult mice (Figure 19). 
 
Figure 19: Oxidation of myofibrillar proteins in the gastrocnemius  
muscle declined with aging. Values are expressed as Mean ± SEM.  
* Indicates significantly different from adult of same sex. 
* * 
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Conclusions –  
Gastrocnemius muscles of female mice exhibited greater oxidation of cytosolic proteins 
(non-contractile) than males, regardless of age. Indicating a sex-dependent preferential 
oxidation of the proteins associated with cell viability. However, myofibrillar proteins 
(contractile) exhibited an age-dependent effect on oxidation that was not impacted by 
sex. These results led to the question, what are the contributions of ovarian hormones to 
the alterations in oxidative damage to muscles following contractions? Based on the 
results observed in this study, it is likely that ovarian hormones play a role. To further 
explore the direct effects of ovarian hormones on muscle protein oxidation, an additional 
study utilizing ovariectomized female mice was performed.  This study investigated the 
age-independent effects of ovarian hormones on oxidation of proteins in skeletal muscle 
of adult and aged female mice.  
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Study 3 – Part B:  
 
Hypothesis –  
Removal of ovarian hormones will result in increased oxidative damage in skeletal 
muscles. 
 
Study Design –  
Adult female C57BL6 mice were obtained from the National Institute of Health Aging 
Colony at 3 months of age. Mice were randomly assigned to be maintained as controls 
(n=4) or to undergo ovariectomy. Mice that underwent ovariectomy were maintained for 
either 3 months (n=5) or 8 months (n=5) in a hormone deficient state. Vaginal cytology 
was taken for 4 consecutive days to verify successful ovariectomy. At the conclusion of 
the hormone deprivation, mice were anesthetized and subjected to in vivo electrically 
stimulated muscle contractions, as described in Study #1 – part A. Following the bout of 
in vivo exercise, mice were injected with Sodium Pentobarbital (100 mg/kg). 
Approximately 30 minutes post-exercise, gastrocnemius muscles were excised, flash 
frozen in liquid nitrogen, and stored at -80°C. At the time the oxidative damage assay 
was performed, the medial head of the frozen gastrocnemius muscle was homogenized, 
fractionated, and assayed for oxidized proteins using the biotin hydrazide marker, as 
described in detail in the methods section of Study #3- part A.  
 
Statistics –  
Because expected variability was unknown at the time of the study, group sizes were 
determined based on what is commonly seen in the literature.  Data were analyzed using 
a one-way ANOVA and a Holm-Sidak post-hoc test was implemented to determine 
significant differences between groups. All statistical calculations were performed on 
Sigma Stat statistical software. 
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Results –  
There was no effect of ovariectomy on the oxidation of cytosolic proteins (p = 0.729, 
Figure 20). 
 
Figure 20: Ovarian hormone deficiency does not  
affect levels of oxidized cytosolic proteins in the  
gastrocnemius muscle of female mice. Values are  
expressed Mean ± SEM 
 
There was an impact of ovariectomy on the oxidation of myofibrillar proteins (p = 0.028). 
After 8 months of ovariectomy, levels of oxidized myofibrillar proteins were 75% higher 
than control (post-hoc p=0.047, Figure 21). 
*	
 
Figure 21: Eight months of ovarian hormone deficiency results  
in increased levels of oxidized myofibrillar proteins in the  
gastrocnemius muscle of female mice. Values are expressed  
as Mean ± SEM.* indicates significantly different from control. 
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Conclusions –  
Ovariectomy did not impact oxidation of cytosolic proteins (non-contractile) and had the 
opposite effect on the oxidation of myofibrillar proteins (contractile) than anticipated 
based on the results of study #3- part A. Mice ovariectomized for eight months had 
higher levels of myofibrillar protein oxidation than control mice and mice ovariectomized 
for three months. This is in contrast to study #3- part A where male mice (no ovarian 
hormones) had lower levels of cytosolic oxidation than female mice and aged mice 
(ovarian senescent females) had lower levels of myofibrillar protein oxidation. The 
results of study 3 suggest that there are independent effects of age and ovarian hormone 
deficiency on protein oxidation in skeletal muscle. 
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Chapter Discussion –  
 
Taken together, the results of studies #2 and #3 indicate that there are effects of both 
aging and ovarian hormones on oxidative stress and oxidative damage to muscle proteins. 
Specifically, under conditions of advanced age and ovarian hormone deficiency there is a 
robust increase in total biopterin, indicating greater de novo synthesis of BH4, a necessary 
co-factor for NOS activity, and suggesting alterations in NOS handling when ovarian 
hormones are lacking.  These results lend further support for a global impact of ovarian 
hormones on BH4 and ultimately oxidative stress [261]. 
 
These studies also give evidence for sex differences in oxidation of cytosolic proteins that 
do not appear to be driven by female sex hormones.  Previous studies focused on 
alterations with aging in males have yielded mixed results. Several have indicated 
minimal impact of aging on oxidative stress following exercise [149, 262, 263] whereas 
others have demonstrated age-associated changes [264-266]. The age-associated changes 
to skeletal muscle oxidation in females observed in study #3 are novel and contribute to 
our understanding of regulating factors of oxidation in skeletal muscle with aging. The 
protective effects of ovarian hormones on skeletal muscle observed in these dissertation 
studies are consistent with what would be expected based on the literature in other 
tissues, specifically that estrogens can be protective against oxidation [18, 172, 173, 267, 
268]. Oxidation of proteins results from an REDOX system imbalance, either due to an 
increase in reactive oxygen and nitrogen species or from a decrease in antioxidants. There 
is minimal evidence to indicate which of these is the mechanism by which estrogens are 
protective; the latter possibility (i.e., antioxidants) was explored further in the studies 
reported in chapter 4. 
 
Finally, the results of the studies in this chapter provide evidence for a decline in 
oxidation of myofibrillar proteins with aging, which is in contrast to much of what has 
been shown in proteins of other highly metabolic tissues such as the kidney and liver 
[269-271] and heart [272]. The reduced oxidation of myofibers with aging appears to be 
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independent of declining ovarian hormones as both males and female exhibit similar 
declines. Furthermore, protein oxidation was greater in muscles of ovariectomized 
females following eight months of hormone deprivation. Only a few studies have 
measured skeletal muscle protein oxidation in both female and male rodents; the results 
of which indicated increased oxidation with aging, particularly in male rats [273, 274]. 
Previous studies did not seek to investigate the differences in oxidation status between 
contractile and non-contractile muscle proteins, which could account in part for the 
discrepancies between results of those studies and the ones performed in this dissertation.  
 
Higher levels of oxidation in contractile proteins, as shown in Figure 21, would suggest a 
resulting decrement in muscle strength and power; however, based on the results of study 
#1, such a force decrement was not observed. Several other studies seeking to investigate 
the interplay between oxidative damage and muscle function have also been unsuccessful 
in teasing apart the mechanisms through which sarcopenia and force loss occur [173, 253, 
275, 276] . Nonetheless, the results of this study elucidate specifically the impact of 
ovarian hormone deficiency on oxidative damage to muscle proteins and provide a novel 
contribution to the field.   
 
The disparate results of study # 3 following a long-duration of ovariectomy compared to 
short-term ovariectomy highlight the importance of investigating multiple time points and 
ages. However, without additional studies it is not possible to rectify the underlying 
causes of the altered REDOX mechanism that occurs following long-term hormone 
deprivation. Thus, to further investigate the impacts of aging and ovarian hormone 
deficiency at multiple ages on redox balance of skeletal muscle tissue, additional studies 
on key antioxidants were performed.  
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Chapter #4: Effects of aging and ovarian hormone deprivation on antioxidant 
protein expression in skeletal muscle 
 
Previous research has provided evidence for an alteration of antioxidant adaptability in 
skeletal muscle with aging, but the impact of sex is not well established. Furthermore, 
minimal research has been undertaken to investigate the effects of estradiol and ovarian 
hormones on antioxidant response. Previous work in our laboratory [37] and others [277-
281] has supported an impact of estradiol on gene regulation of antioxidants. However, 
the effects of age and hormonal status on antioxidant protein expression remain to be 
assessed and are arguably more critical to maintaining muscle redox balance than is gene 
expression. As such, the following studies investigate the impact of sex and estradiol on 
antioxidant protein expression in aged compared to adult mouse muscle. This information 
may help to explain results reported in the previous chapter of this dissertation, for 
example, why myofibrillar protein oxidation is elevated in muscle in response to 8 
months of ovarian hormone deficiency (Figure 21). The literature suggests some increase 
in ROS production with age [248, 249]; however, study #2 found no impact of age on 
global levels of oxidative stress in female mice aged 28 months. Therefore, is the change 
in oxidative damage of the gastrocnemius muscle (observed in study #3) due to 
alterations in antioxidant protein expression? 
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Study #4 – Part A: 
 
Hypothesis –  
Antioxidant proteins are decreased in skeletal muscle with aging in females but not 
males. 
 
Study Design –  
Male and Female C57BL6 mice aged 4 months (n = 4 of each sex) and 28 months (n = 5 
of each sex) were obtained from the National Institute of Health Aging Colony. Mice 
were anesthetized and subjected to in vivo electrically stimulated muscle contractions, as 
described in Study #1 – part A. Following the bout of in vivo exercise, mice were injected 
with Sodium Pentobarbital (100 mg/kg). Gastrocnemius muscles were excised 
approximately 30 minutes following the completion of the exercise bout. The remaining 
gastrocnemius muscle tissue, not used for the oxidative damage assay, was homogenized, 
as described in detail in the methods sections of Study #3- part A. Following 
homogenization with acid to prevent further oxidation of antioxidants, tissue homogenate 
was fractionated and assayed for protein expression of antioxidants, as described in the 
methods below. 
 
Statistics –  
Because expected variability was unknown at the time of the study, group sizes were 
determined based on what is commonly reported in the literature. Data were analyzed 
using a two-way ANOVA (age x sex). For all statistically significant interactions, a 
Holm-Sidak post-hoc test was implemented. All statistical calculations were performed 
on Sigma Stat statistical software. 
 
Methods –  
 
Antioxidant blots 
For the western blots assessing the effects of estradiol deprivation, sex, or aging on 
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antioxidant proteins in muscle, cytosolic fractions of muscle homogenate prepared at a 2-
mg/mL concentration with Laemelli sample buffer were thawed. Samples were heated at 
95°C for 5 min prior to loading on a 10% gel. An all blue protein standards ladder and a 
positive control of HeLa cell lysate were loaded on all gels. Gels were run on Biorad 
(system info) in a 4°C cooler for 60 minutes at 150V. This time was chosen as it is long 
enough to achieve separation of proteins on the gel but not so long as to run small 
proteins off the gel.  Gels were transferred to methanol soaked-PVDF membrane in a 4°C 
cooler overnight at 30V. Gels were chosen at random to be coomassied for remaining 
proteins. Coomassie indicated that all proteins had successfully transferred to the 
membrane.  
 
Membranes were blocked in LiCor PBS blocking buffer for 90 minutes, prior to adding 
primary antibodies and tween. Membranes were incubated with primary antibodies for 
anti-NAPDH oxidase 4 (abcam, ab1333303), anti-superoxide dismutase 1 (abcam ab 
16831), anti-superoxide dismutase 2 (abcam, ab16956), anti-catalase (abcam, ab16731), 
and anti-GAPDH loading control (abcam, ab9483), at concentrations recommended by 
manufacturers, on a rocker in a 4°C cooler overnight. The following morning, 
membranes were washed 4 x 15 min in PBST, then incubated with the appropriate 
species secondary antibody for 60 min on a rocker in a dark box at room temperature. 
Membranes were again washed 4 x 15 min in PBST and then imaged on a LiCor 
Odessey. Images were quantified using LiCor software. Quantification boxes were drawn 
around each sample band and the signal was normalized to the loading control, GAPDH, 
for that sample (Figure 22).  
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Figure 22: Representative antioxidant protein western blots showing example muscle 
cytosolic fraction from 4 month, 24 month, and 28 month female mice as well as 
positive control of HeLa cells for A) NOX4, B) SOD2, and C) GAPDH (loading control 
for normalization to total protein in each lane). 
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Figure 22: Representative antioxidant protein western blots showing example muscle 
cytosolic fraction from 4 month, 24 month, and 28 month female mice as well as 
positive control of HeLa cells for A) NOX4, B)SOD2, and C) GAPDH (loading control 
for normalization to total protein in each lane).
 
 
Blots for the antioxidant protein, GPX 3, required additional enrichment of the sample 
fraction due to the low abundance of the protein. For this antioxidant, a mitochondrial 
fraction was separated from the myofibrillar fraction. This was accomplished by further 
lysing cells of homogenates through an 18 gauge and then a 21 gauge needle. Sample 
homogenates were then spun at 1000g to bring down myofilaments and the supernatant 
was pipetted off and concentrated via methanol precipitation. Pellets were re-suspended 
in 30-50uL of PBS buffer with 6X Lamelli sample buffer. Samples were then heated, 
loaded and run as previously described for other western blots of antioxidants. The 
primary antibody utilized was anti-glutathione peroxidase 3 (abcam, ab104448). 
 
Following quantification of GPX 3 signal, membranes were stained with Licor REVERT 
total protein stain and imaged for total protein content. Total protein of each lane was 
measured and GPX 3 signal was normalized to total protein. This was necessary because 
GAPDH is not expressed in the mitochondrial fraction, and common mitochondrial 
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loading controls are associated with the electron transport chain, which can be affected by 
oxidative stress. 
 
Results –  
There was an interaction between age and sex for NOX4 expression (p=0.006). Adult 
female mice had 11.8-fold greater expression than adult males; however, aged females 
had similar expression as aged males (post-hoc p<0.001, Figure 23). 
*
 
Figure 23: Aging impacts NOX4 expression differentially in  
the gastrocnemius muscle of male and female mice. Values  
are expressed as Mean ± SEM. *Indicates significantly  
different from adult male and aged male and female. 
 
 
There was a main effect of aging on protein expression of SOD1 (p < 0.001). 
Gastrocnemius muscles from 28 month-old male and female mice had less SOD1 protein 
than those from 4 month-old mice. There was no effect of sex on SOD1 expression (p= 
0.231, Figure 24). 
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Figure 24: There is an impact of age on SOD1 protein  
expression in gastrocnemius muscle of male and female  
mice. Values are expressed as Mean ± SEM. * Indicates  
significantly different from same sex adult.  
 
There was no effect of aging on protein levels of SOD2 (p = 0.676). There was a main 
effect of sex on protein expression of SOD2 (p = 0.003). Females have 3.2-fold greater 
expression than males (Figure 25). 
 
Figure 25: There was an effect of sex on protein expression  
of SOD2 in gastrocnemius muscle of mice. Values are  
expressed as Mean ± SEM. † Indicates significantly different  
from male at same age. 
 
 
 
* 
†
	 
†
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There was no effect of aging or sex on protein expression of catalase in gastrocnemius 
mouse muscles (p = 0.236 and p = 0.399, respectively, Figure 26). 
 
Figure 26: Catalase in gastrocnemius muscles was not  
different among adult and aged female and male mice.  
Values are expressed as Mean ± SEM. 
 
There was an interaction between age and sex for protein expression of GPX3 (p =0.038). 
There is no difference in expression levels between adult males and females (post-hoc p 
=0.546); however, aged females have 1.6-fold greater expression than aged males (post-
hoc p = 0.020, Figure 27). 
*
 
Figure 27: Aging impacts GPX3 expression differentially in  
the gastrocnemius muscle of male and female mice. Values  
are expressed as Mean ± SEM. * Indicates significantly  
different from adult and aged male.  
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Conclusions –  
The impact of aging on antioxidant protein expression is antioxidant-specific, that is, 
some antioxidants are affected while others are not. Overall skeletal muscles from female 
mice appear to be more severely impacted by aging than those from male mice. 
Gastrocnemius muscles from aged males and females exhibit lower levels of SOD 1 
expression compared to adults, and magnitude of decline is particularly large in female 
mice. Protein expression of NOX4 and GPX3 was affected differentially by aging in 
males and females. Aging did not impact expression of either protein in muscles from 
male mice; however, in female mice NOX4 levels were higher in aged mice whereas 
GPX3 levels were lower in these same mice. These results are suggestive of an aging-
induced shift present only in the female mice.  
 
The only protein to demonstrate sensitivity to sex was SOD2; female mice had higher 
levels of SOD2 in skeletal muscle regardless of age. Estradiol has been shown to increase 
SOD2 expression through estrogen receptors in the vasculature [278]; however, the 
results of this dissertation are the first to demonstrate an effect of sex on SOD2 protein 
expression in skeletal muscle. Collectively, the results provide strong evidence for an 
effect of aging on protein expression of antioxidants, particularly in female mice. 
Furthermore, for certain aspects of the SOD/Glutathione pathway, the response to aging 
is different in males and females. Evidence from previous work in our lab has supported a 
role for estradiol in antioxidant gene regulation in skeletal muscle [37]. Thus, a final 
study was conducted to determine the role of estradiol in modulating the expression of 
antioxidant proteins. 
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Study #4 – Part B: 
 
Hypothesis –  
Estradiol deficiency will result in decreased protein levels of antioxidants in skeletal 
muscle from female mice.  
 
Study Design –  
Adult and aged female C57BL6 mice were obtained from the National Institute of Health 
Aging Colony at 3 and 20 months of age. Mice were randomly assigned to be maintained 
as controls (adult n=4, aged n=4) or to undergo ovariectomy (adult n=6, aged n=6). 
Ovariectomy was verified by vaginal cytology. At the conclusion of the hormone 
deprivation, mice were anesthetized and subjected to in vivo electrically stimulated 
muscle contractions, as described in Study #1 – part A. Following the bout of in vivo 
exercise, mice were injected with Sodium Pentobarbital (100 mg/kg). Exercise was 
employed as a stressor to induce an antioxidant response in skeletal muscle. Baseline 
alterations with aging are less so impacted than response/ability to up-regulate in 
response to stress [263]. Furthermore, it has been suggested that the ability of tissues to 
respond to stressors (i.e., plasticity), is largely impacted by aging and has negative 
consequences for REDOX balance [282]. Approximately 30 minutes post-exercise, 
gastrocnemius muscles were excised, flash frozen in liquid nitrogen, and stored at -80°C. 
The remaining gastrocnemius muscle tissue, not used for the oxidative damage assay, 
was homogenized, fractionated, and assayed for protein expression of antioxidants, as 
described in detail in the methods sections of Study #3- part A and Study #4- part A.  
 
Statistics –  
Because expected variability was unknown at the time of the study, group sizes were 
determined based on what is commonly seen in the literature.  Data were analyzed using 
a two-way ANOVA (age x ovarian status). For all statistically significant interactions, a 
Holm-Sidak post-hoc test was implemented. All statistical calculations were performed 
on Sigma Stat statistical software. 
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Results –  
There was a main effect of aging on protein expression of NOX4 in skeletal muscle 
(p<0.001); levels were lower in aged mice compared to adult. There was no effect of 
ovarian status on NOX4 expression (p=0.213; Figure 28). 
 
Figure 28: Aging impacts NOX4 protein expression  
in the gastrocnemius muscle of female mice.  
Values are expressed as Mean ± SEM. * Indicates  
significantly different from adult. 
 
There was a main effect of age (p=0.021) but not ovarian status (p=0.095) on SOD1 
expression (Figure 29). Specifically, SOD1 protein levels were 0.7-fold lower in 
gastrocnemius muscles of aged mice compared to adult mice. 
 
Figure 29: Aging impacts SOD1 protein expression  
in the gastrocnemius muscle of female mice.  
Values are expressed as Mean ± SEM. * Indicates  
significantly different from adult. 
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There was a main effect of age on SOD2 protein expression (p=0.018); aged mice had 
0.6-fold lower levels than adult mice. There was no effect of ovarian status on SOD2 
expression (p=0.183, Figure 30). 
 
Figure 30: Aging impacts SOD2 protein expression  
in the gastrocnemius muscle of female mice.  
Values are expressed as Mean ± SEM. * Indicates  
significantly different from adult. 
 
There was no effect of age (p=0.468) or ovarian status (p=0.924) on protein expression of 
catalase (Figure 31). 
 
Figure 31: There is no effect of age or ovariectomy  
on protein expression of catalase in the gastrocnemius  
muscle of female mice. Values are expressed as  
Mean ± SEM.  
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There was a significant interaction between age and ovarian status on GPX3 protein 
expression in gastrocnemius muscles (p=0.008). Levels of GPX3 were higher in aged 
control mice compared to adult control and adult OVX mice (post-hoc p<0.001). 
Whereas ovariectomy did not impact GPX3 expression in adult mice (post-hoc p=0.515), 
removal of ovarian hormones in aged mice resulted in lower levels of expression (post-
hoc p<0.001, Figure 32). 
 
Figure 32: Ovariectomy impacts GPX3 expression differentially  
in the gastrocnemius muscle of adult and aged female mice.  
Values are expressed as Mean ± SEM. * Indicates significantly  
different from adult control, adult OVX, and aged OVX. 
 
 
Conclusions –  
There appear to be ovarian hormone-independent effects of aging on multiple 
antioxidants in skeletal muscle. Specifically, NOX4, SOD1 and SOD2 were lower in 
gastrocnemius muscle of aged female mice compared to muscle from adult female mice. 
The decline in antioxidant response following exercise is suggestive of a loss of redox 
plasticity in the muscle of aged females. To definitively show that plasticity is lost, 
additional control groups (muscles that were not exercised prior to excision) would need 
to be included. There was no impact of ovarian status on protein expression of NOX4, 
SOD1, or SOD2 following exercise. Although these data do not support what has been 
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previously shown at a gene levels, it is possible that the effects of estradiol are small 
compared to the impact of exercise and as such any hormone-driven alterations are 
overshadowed. 
 
There was no impact of age or ovarian status on catalase protein expression, once again 
highlighting the importance of superoxide dismutase as key antioxidants altered by aging 
and loss of ovarian hormones. The significant interaction between age and ovarian status 
that was identified for GPX3 suggests an alteration in dismutase of superoxide into less 
hazardous forms or a change in the recycling of Glutathione (Figure 1). One possible 
explanation is that alterations upstream that occur as a result of aging (i.e., decline in 
levels of superoxide dismutase) may be putting additional demands on the actions of 
glutathione and glutathione peroxidase to neutralize additional radicals not handled by 
superoxide dismutase. 
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Chapter Discussion –  
 
The results of study #4 demonstrate an age-associated decline in antioxidant proteins, 
SOD1 and NOX4, in exercised gastrocnemius muscles of female mice aged 24 and 28 
months, compared to those of 6 month-old female mice. However, based on the results of 
studies #1 and #3, this does not appear to translate to an increase in overall muscle 
protein oxidation or a loss of muscle contractile function. The decline in protein 
expression of SOD1 with age in females is consistent with that observed in males, and is 
in agreement with other literature in male mice [202, 283]. Genetic removal of SOD1 has 
been demonstrated to induce oxidative stress and result in an accelerated aging phenotype 
[201], indicating the importance of this protein in mitigating oxidative stress. Unlike 
SOD1, the response of NOX4 protein expression to aging is sex-specific; the a decline in 
NOX4 expression observed in aged females was not observed with aging in muscle of 
male mice. This could be due to the differing levels throughout life (adulthood as well as 
aging) or could be indicative of an altered aging response in females and could relate to 
the decline of ovarian hormones following ovarian senescence in female mice. However, 
there did not appear to be an independent ovarian-hormone effect on protein expression 
of SOD1 or NOX4 in adult or aged female mice. Thus, it can be concluded that the aging 
effects are independent of the decline in ovarian hormone production.  
 
The results of this study suggest a critical transition in skeletal muscle between 24 and 28 
months of age in female mice. There was no impact of aging on protein levels of SOD2 
in 24 month old females compared to adult; however, by 28 months of age a substantial 
decline in protein levels was observed. These detrimental changes are mirrored by muscle 
function, specifically muscle power production (e.g., loss of muscle function was not 
apparent until 28 months of age in study #1). These results add to our understanding of 
the role that SOD2 plays in maintaining muscle function, particularly with aging [128, 
284]. 
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As would be expected, based on the alterations in NOX4 and SOD1/2, protein expression 
of GPX3 was impacted by age in female mice. Both 24 and 28 month-old female mice 
had higher levels of GPX3 protein than adult females. However, there appears to be a 
detrimental impact of ovarian hormone deficiency on muscle from aged mice that is not 
observed in the adult mice. This finding gives evidence for the importance of using old 
mice for aging studies and not relying only on young models of aging.  
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Chapter #5: Conclusions and Discussion 
 
The final chapter of this dissertation summarizes the research findings on the impact of 1) 
ovarian hormones and then 2) aging in regard to skeletal muscle contractile function and 
oxidation. The final section provides insight into possible future areas of investigation 
that would build upon the results of these dissertation studies.  
 
 
Effects of ovarian hormones on skeletal muscle strength and power, oxidative damage, 
and antioxidant protein expression 
 
As discussed in detail in chapter #1, although studies have investigated the impact of 
ovarian hormones (and in particular estradiol) on skeletal muscle function, there have 
been conflicting results not only in rodent literature but in human literature as well. Since 
this dissertation focused on utilizing a mouse model to investigate the impact of ovarian 
hormones on skeletal muscle at not only a functional level but also at a cellular level, this 
discussion is focused on comparisons to existing rodent literature. The meta-analysis 
previously published by our lab highlighted a slight overall positive impact of estradiol 
on muscle function in mice with some, but not all studies supporting improved force 
generation with estradiol [104]. In looking more closely at individual studies, the positive 
impact of ovarian hormones appears to be noted primarily in studies where muscle 
strength was measured ex vivo [14, 15, 18, 83, 107, 108, 285].  The decline in function 
was also measured at the level of myosin in skinned muscle fibers and specifically 
showed that the muscle quality (fraction of myosin in strong-binding state) and not 
quantity of contractile proteins was driving the decline in strength [15, 107, 285].  
 
 
 
The positive impact of estradiol on muscle strength observed ex vivo does not completely 
translate to muscle contractility tested in situ or in vivo. Consistent with results of this 
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dissertation, previous literature also demonstrate that ovarian hormones, and in particular 
estradiol, do not impact maximal muscle strength [223, 286, 287]. The only positive 
impact found for ovarian hormones was on sub-maximal strength elicited by low 
stimulation frequencies [287]. As already discussed, most studies investigate the impact 
of ovarian hormones on maximal isometric strength of muscles; the impact on sub-
maximal strength and strength produced at velocity is rarely considered. Thus, results of 
this dissertation add considerable insight into the impact of ovarian hormone removal on 
more functionally relevant measures of muscle strength.  
 
Results from study #1 of this dissertation found minimal impact of ovarian hormones on 
maximal isometric torque, in agreement with the existing literature, and also minimal 
impact on sub-maximal isometric torque and muscle power. The effect of ovarian 
hormones on skeletal muscle function did not appear to be age-dependent as removal of 
ovarian hormones from mice at 6 or 24 months of age yielded similar results. 
Furthermore, longer duration of ovarian hormone deficiency, up to 12 months, did not 
induce additional changes in muscle function. The majority of studies investigating 
ovarian hormones are performed on adult mice. It is important to know that muscle of 
aged mice appear to respond similarly to hormone deprivation providing insight into the 
role of ovarian hormones across the lifespan. Thus in mice, it can be speculated that 
ovarian hormones are providing similar input to skeletal muscle function in adulthood 
and during aging.  
 
Despite the minimal impact of ovarian hormones on muscle function in vivo, several key 
alterations were noted at a cellular level. Ovarian hormone deprivation resulted in a 
global decline of nitric oxide availability. Results of study #2 suggest that nitric oxide 
handling in the body may rely on ovarian hormone regulation. When ovarian hormones 
are absent, production of BH4 (an ultimately nitric oxide) is increased, indicating a lack 
of nitric oxide available for tissue utilization. These results lend support for a critical role 
of ovarian hormones in nitric oxide regulation and are in agreement with what has been 
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previously reported in skeletal muscle and other tissues of the body as summarized 
below.  
 
The impact of estradiol on nitric oxide production has been shown to be tissue-
dependent; with estradiol resulting in up-regulation of nitric oxide in endothelial cells, 
immune cells, and nerve cells [288-291], but down-regulation in tissues such as the brain 
and liver [292-294]. In skeletal muscle, nitric oxide plays a role in muscle fatigability, 
fiber type determination, and post-exercise force recovery [295], as well as many other 
cellular aspects of muscle function and energy metabolism [296]. It has been speculated 
that ovarian hormones, particularly estradiol, likely impact vaso-modulation (i.e., 
vasoconstriction and vasodilation) of skeletal muscles during contraction [297-300]; 
however, current evidence is more correlative than causal.  
 
The reasons for this tissue-disparity are not understood, but could be related to the 
metabolic nature of the tissue (e.g., the brain and liver are highly metabolic whereas 
nerves and endothelium are less so). The specific pathway of estradiol regulation on nitric 
oxide may occur through estrogen receptors, the expression of which has been shown to 
correlate with nitric oxide, specifically changes that occur with aging [301]. Based on the 
results of this dissertation, it seems possible that estradiol increases nitric oxide synthesis, 
as speculated in Figure 33. Showing cause and effect among these complicated pathways 
in skeletal muscle will require further investigation, as outlined in the future studies 
section below. 
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Figure 33: Speculated impact of ovarian hormones on nitric oxide synthesis and antioxidants in skeletal muscle. 
 
 
Alterations in redox signaling have been implicated in age-related decline of cellular 
function specifically in skeletal muscle [231, 302-309] . This dissertation sought to 
investigate the impact of redox signaling, in particular antioxidant response, on 
alterations in muscle function. In order to evoke an antioxidant response, exercise was 
used to perturb the muscle and activate REDOX pathways.  
 
Oxidative-induced changes in muscle could preferentially occur to contractile proteins or 
non-contractile proteins. Results of study #3 demonstrate an impact of sex on oxidation 
specifically of non-contractile muscle proteins. Although females exhibited greater levels 
of oxidation than males, this was not impacted by removal of ovarian hormones in 
females. Previous studies have suggested that ovarian hormones may be protective of 
oxidative damage to cardiac and skeletal muscle in females [18]. But on the whole, 
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evidence is severely lacking in the literature with only one study investigating the 
influence of sex on damage in muscle [310] , and no studies investigating the impact of 
sex on contractile versus non-contractile proteins within skeletal muscle. The results of 
this dissertation lend support for a sex difference in oxidation of non-contractile proteins 
that is not driven by ovarian hormones. 
 
Contrary to non-contractile proteins, oxidation of contractile proteins in skeletal muscle 
does appear to be impacted by ovarian hormones. As hypothesized, removal of ovarian 
hormones in females resulted in increased levels of oxidation. To date no studies 
investigating oxidation of contractile proteins in females have been published. The 
existing studies in females have not differentiated between contractile and non-contractile 
proteins within muscle [18]. The results of this dissertation give evidence that deficiency 
of ovarian hormones results in the oxidation of contractile proteins in skeletal muscle. 
The mechanisms through which the presence of ovarian hormones confers this protective 
effect are relatively unknown. However, post-translational modifications of myosin have 
shown estradiol sensitivity [16] and it can be speculated that mechanisms may be similar. 
 
The studies of this dissertation sought to further probe the mechanism of ovarian 
hormone protection against oxidation in skeletal muscle by investigating levels of 
antioxidant protein expression. Previous studies on the relationship between estradiol and 
antioxidants in skeletal muscle are limited, have largely focused on the vasculature, and 
have yielded mixed results [206, 311-313]. Estrogen has been shown to regulate 
antioxidant expression at a gene level in skeletal muscle [37] but to our knowledge, study 
#4 of this dissertation provides the first evidence of ovarian hormone impact on protein 
expression of these antioxidants in skeletal muscle. Collectively, the results support the 
hypothesis of this dissertation showing that females have higher levels of key antioxidant 
proteins (specifically SOD2 and GPX3) than males indicative of a sex-differentiated 
response to exercise. In addition, removal of ovarian hormones appears to be of greater 
detriment to antioxidant response to exercise in aged females compared to adults. Taken 
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together, these results lend support for both aging and ovarian hormone related impacts 
on antioxidant expression in skeletal muscle following exercise.  
 
 
Effects of aging on skeletal muscle strength and power, oxidative damage, and 
antioxidant protein expression  
 
Previous studies investigating skeletal muscle contractility in aged female mice utilized 
ex vivo approaches [17], and the current findings provide the first results for in vivo 
muscle functioning in aged female mice. Muscle performance in vivo includes input from 
the nerve and neuromuscular junction (NMJ). There are several changes to the 
neuromuscular junction suggested to occur with aging such as gradual loss of motor 
neuron-innervation [48, 314, 315], NMJ fragmentation [316],and decline of motor neuron 
conduction velocity [317] leading to impaired excitation-contraction coupling. Previous 
studies have shown that age-related declines in SOD1 may be partially responsible for the 
changes in the neuromuscular junction [318-320] and sarcopenia of skeletal muscle [283, 
318]. 
 
The results of study #4 lend further support to declining levels of SOD1 as well as SOD2 
protein expression in skeletal muscle with aging. Furthermore, in female mice the age-
related decline is independent of ovarian hormone status. Due to the importance of SOD1 
in muscle health, studies have suggested that removal of SOD1 would result in a failure 
to adapt to exercise such as that observed in old mice [201]. However, other studies have 
not successfully correlated antioxidant expression with muscle functional outcomes. The 
utilization of an in vivo muscle functional testing approach in study #1 prior to 
measurement of antioxidant proteins allowed for initial information on the relationship 
between antioxidant levels and muscle contractile function to be gleaned. Declines in 
muscle power were not observed until 28 months of age, whereas antioxidant changes 
were present at 24 months of age. The combined results of these dissertation studies show 
that an alteration in antioxidant protein expression precedes declines in muscle strength 
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and power and thus suggest that the loss of protection from oxidative stress in muscle 
may contribute to functional decline.   
 
The impact of aging on oxidative stress and damage is also important to consider when 
investigating antioxidant responses due to the close relationship between stressor and 
response. There was a decline in oxidation of contractile proteins within muscle with 
aging. This is not what would be anticipated based on the existing literature [64, 65, 230, 
321, 322]. However, as previously discussed, most previous studies have utilized males 
and not females. Combined, this suggests that oxidative damage to muscle in mice is 
likely sex-specific. There are limited human studies that also point towards a sex-
specificity of oxidative damage in skeletal muscle, with men being more prone to damage 
than women [306, 323]. One plausible explanation for these dissimilarities observed 
between males and females with aging could be differences in nitric oxide handling. The 
results of study #2 are suggestive of a decrease in nitric oxide availability in aged female 
mice. The nitric oxide theory of aging hypothesizes that high levels of nitric oxide occur 
during aging and these high levels result in increased oxidative damage [324, 325].  
 
High levels of nitric oxide, such as those that may occur with aging, drive the pathway 
preferentially towards increased production of oxidants and result in oxidative damage 
(Figure 34). Although not specifically addressed by this dissertation, there are likely 
alterations in nitric oxide synthase activity with aging as well which can have drastic 
impacts on the vasculature, in particular vasodilation kinetics, in skeletal muscle [326-
328] and may also contribute to loss of muscle function [329].  
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Figure 34: Speculated impact of aging on nitric oxide synthesis and antioxidants in skeletal muscle. 
 
 
Overall, the collective results of these dissertation studies provide the first in vivo 
measurements of skeletal muscle sub-maximal strength and power in aged female mice. 
This information, coupled with the novel insights on the alterations in redox homeostasis 
in skeletal muscle that occur with aging, provides a potential pathway for maintenance of 
muscle function. Lastly, the differences observed between males and females highlight 
the importance of including both sexes when studying aging.  
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Future Directions  
 
Based on the findings of this dissertation, further investigation into the effects of estradiol 
on oxidative stress in skeletal muscle is warranted. Continued work with ovariectomy in 
aged mice should be undertaken, since there is evidence for estradiol-independent effects 
as well as estradiol-dependent effects of aging. Removing ovarian tissue just prior to or at 
the time of senescence would remove some of the senescence-driven variability observed 
in the aged female mice as it would force all mice into a constant low state of estradiol. 
This, potentially coupled with an estradiol treatment, would strengthen the investigation 
of estradiol’s effects with aging. Ideally, this approach would be coupled with serum 
estradiol measurements; however, a current limitation in the field is a lack of sensitive 
assays to measure circulating levels of estradiol in mice. Because the majority of 
commercially available assays are for human application, and mice have such low levels 
of estradiol compared to women (approximately 1/10th the level), mouse serum levels are 
often below the level of detection.  
 
Since the results of this dissertation clearly indicate a strong effect of estradiol and aging 
on superoxide dismutase and downstream antioxidants (e.g., GPX3), additional studies 
utilizing SOD1KO mice could provide insight to the impact of estradiol deprivation on 
this important pathway. This mouse model is considered to be a model of premature 
aging. Utilization of pharmacological approaches in this mouse could further elucidate 
the involvement of the estrogen receptors (ERα and ERβ) on the antioxidant response to 
oxidative stress. To further probe the mechanism through which estradiol may be acting, 
a skmERαKO mouse (mice bred to lack ERα only in the skeletal muscle) could be 
employed. 
 
To further investigate the effects of aging, a mouse model of premature aging, such as the 
ZMP mouse, could be employed. This Progeria model would minimize the cost, time, 
and other limitations of aging mice to 28 months of age; however, this mouse is known to 
be relatively unhealthy, and as such it is possible that they may not experience regular 
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estrous cycles. Cytology would need to be assessed before deciding if this model would 
be useful to study estradiol deprivation (i.e., if the mouse is not cycling it may already be 
in a state of estradiol deprivation and as such it may be more appropriate to investigate 
the addition of estradiol in these mice). 
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